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THE EFFECTS OF ENVIRONMENTAL POLLUTANTS ON ADIPOGENESIS IN THE 3T3-L1 MODEL

by

JING WANG

Under the Direction of Roberta Attanasio (PhD)

ABSTRACT
Humans are continuously exposed to mixtures of environmental pollutants. Polycyclic
aromatic hydrocarbons (PAHs), such as 2-naphthol, and heavy metals, such as lead, are some of
these pollutants. Results from epidemiological studies show associations between exposure to
2-naphthol, exposure to lead, and obesity. However, the individual and combined effects of 2naphthol and lead on fat cell development (adipogenesis) have not been directly characterized
in a biological system. In this study, we evaluated the effects of 2-naphthol and/or lead on
adipogenesis using mouse 3T3-L1 cells.
Cells were exposed to different doses of 2-naphthol and/or lead. Induced terminal
differentiation was evaluated by cell morphology, lipid production, and mRNA expression of

marker genes characteristic of either early adipocyte differentiation: CCAAT-enhancer-binding
protein β (C/EBPβ), insulin receptor substrate 2 (IRS2), and sterol responsive element binding
protein 1 c (SREBP1c); or terminal differentiation: C/EBPα, peroxisome proliferator-activated
receptor-γ (PPARγ), and fatty acid binding protein 4 (aP2). Production of antimicrobial peptide
cathelicidin (Camp), which is produced by differentiating adipocytes and modulates inflammation
and immunity, was also evaluated.
Cell morphology changes and increased lipid accumulation indicated that, individually, 2naphthol and lead induced 3T3-L1 differentiation; however, the highest dose of lead (10 μM)
showed the lowest induction level. During terminal differentiation, 2-naphthol and low doses of
lead increased C/EBPα, PPARγ, and aP2 expression, whereas 10 μM lead suppressed PPARγ and
aP2. During early differentiation, 2-naphthol stimulated C/EBPβ, IRS2, and SREBP1c expression,
while lead upregulated C/EBPα and aP2. The 2-naphthol/10 μM lead mixture induced a
counterbalancing effect on 3T3-L1 adipogenesis, where 10 μM lead suppressed 2-naphtholinduced adipogenesis. Moreover, 2-naphthol elevated Camp expression in a dose-dependent
manner, whereas lead slightly increased Camp at lower doses but suppressed it at 10 μM. The 2naphthol/10 μM lead mixture showed no effect on Camp expression.
In conclusion, 2-naphthol and low lead doses accelerate adipocyte differentiation and
Camp production in 3T3-L1 cells; however, high doses of lead attenuate the induction. This effect
of lead at high dose counterbalances the upregulation of adipocyte differentiation and Camp
production by 2-naphthol. Together, these findings indicate that 2-naphthol and lead play
potential roles in the development of inflammation and obesity.
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Antimicrobial peptide
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1.1

Chapter 1: Introduction

Environmental pollution: an increasing global issue
Environmental pollution is caused by human activities that produce excessive harmful by-

products. Such production oversteps far beyond the capacity of the environment to process and
neutralize them. Environmental pollution has been a growing global issue since the onset of the
Industrial Revolution during the 19th century. Technological progress facilitated the exploitation
of natural recourses, such as coal and fuel, and their universal utilization throughout different
industries. The development of natural sciences, especially chemistry, led to a novel model of
developing new chemicals—search or create first, and understand later—which impacted the
industry in the 20th century, and still does. In contrast, relatively little information has been
generated on the effects of these chemicals on the environment and health.
In February 2015, the Centers for Disease Control and Prevention (CDC) updated the
biomonitoring data of national exposure to environmental chemicals for the Fourth National
Report on Human Exposure to Environmental Chemicals, 2009. This report presents exposure
data for a total of 265 chemicals measured in blood and urine samples from participants in the
National Health and Nutrition Examination Survey (NHANES) since 1999 (CDC 2015). Among
these 265 environmental chemicals, several chemicals, such as bisphenol A (BPA),
polychlorinated biphenyls (PCBs), and o,p'-Dichlorodiphenyltrichloroethane (DDT) had already
been reported to have adverse effects on human health (Schug et al. 2011).
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1.2

Environmental pollutants and their effects on health

1.2.1 Types and sources of environmental pollutants
Environmental pollutants exist in gaseous, solid, or liquid form, and are usually present in
the environment as a mixture of different types of chemicals. Environmental pollutants can be
simply categorized into three major types: soil pollutants, water pollutants and air pollutants.


Soil pollutants, found on the earth’s land surface, are mainly heavy metals, crude oil and
coal tars, pesticides and herbicides, and organic or radioactive chemicals, deriving from
mining, agricultural materials, and household and industrial waste.



Water pollutants are contaminants that reach the water system including rivers, lakes,
oceans, and other water sources.



Air pollutants, which exist in the earth’s atmosphere, are mainly generated by human
activities, such as burning of fossil fuel and coal, smoking, industrial and vehicle exhausts,
and certain household products. Carbon monoxide, lead, nitrogen dioxide, ozone, sulfur
dioxide, and particulate matters are the most common air pollutants.
Based on the cellular mechanisms by which environmental pollutants exert their adverse

health effects, environmental pollutants can be grouped into three categories:
1.

Pro-oxidants and free radicals generators (e.g., ozone and nitrogen oxides)

2.

Endocrine disruptors (e.g., BPA)

3.

Heavy metal (e.g., cadmium)

1.2.1.1 Pro-oxidants and free radicals generators
Some environmental pollutants are potential oxidants, and are able to directly or
indirectly oxidize tissue and cellular components, such as lipids, proteins and DNAs, or to
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generate reactive oxygen species (ROS) and free radicals, resulting in oxidative stress and
inflammation, which finally lead to harmful health effects. Ozone, nitrogen oxides, carbon
monoxide, sulfur oxides, and particulate matter less than 2.5 and 10 μm in diameter (PM 2.5, PM10)
all belong to this category. The ROS or free oxygen and nitrogen radicals induced by ozone and
nitrogen oxides are able to initiate lipid peroxidation from unsaturated and polyunsaturated fatty
acids, and thiol proteins. This biological process produces various byproducts that may promote
oxidative damage to the target tissues and modify the function of target proteins. Ozone and PM
initiated redox state is able to activate nuclear factor-κB (NFκB), a transcription regulator that
controls gene transcription of pro-inflammatory cytokines and proteins involved in inflammation
and immune responses (Yang and Omaye 2009).
This category of environmental pollutants is mainly generated from the combustion of
fossil fuels. Nitrogen oxides and volatile organic compounds are emitted from fuel-based
transportation and stationary combustion sources, such as power plants. Carbon monoxide
results from incomplete combustion, as well as from vehicle exhaust. Sulfur oxides are produced
by combustion of coal and heavy oils or smelting metal ores that contain Sulphur. The major
sources of PM are motor vehicles, industrial processes, fuel combustion by power plants, fires,
and dust from natural wind (Kampa and Castanas 2008; Katsouyanni 2003; Poschl 2005).
1.2.1.2 Endocrine disruptors
Endocrine-disrupting chemicals (EDCs), also called endocrine disruptors, are a large group
of natural or synthetic chemicals that show hormone-like activities. Because of these hormonelike characteristics, this group of chemicals is capable of interfering with endogenous hormone
homeostasis (synthesis, secretion, transport, and metabolism) and physiological regulatory
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functions of endocrine signaling pathways and systems. The adverse effects of EDCs on glands
and hormone-regulated functions include complications of growth, reproduction, stress
response, sex and gender development, and insulin function (Newbold 2010). EDCs are
commonly found in many industrial and agricultural products, including coolants and lubricants
such as polychlorinated biphenyls (PCBs); plasticizer like bisphenol A (BPA) and di-2-ethlhexyl
phthalate; herbicides, fungicides and pesticides such as carbamates, endrin, lindane and
dichlorodiphenyltrichloroethane (DDT). EDCs may also be present in household and everyday
products—including detergents, flame retardants (i.e. polybrominated biphenyls), plastics, toys,
pharmaceuticals, food, and solvents in cosmetics.
EDCs exert their endocrine disrupting effects by imitating or antagonizing the actions of
steroid hormones, including testosterone, estrogen, thyroid hormone, progesterone, cortisol,
lipids or fatty acids. Through binding to nuclear hormone receptors, EDCs can alter target gene
transcription (Diamanti-Kandarakis et al. 2009; Janesick and Blumberg 2011). One example is the
synthetic estrogen diethylstilbestrol (DES), used during the 1940s-1970s for pregnant women.
Prenatal and developmental exposure to DES results in teratogenic or carcinogenic syndrome in
the female reproductive tract. The DES toxic effect on gene expression and tissue differentiation
is mediated by the estrogen receptor alpha (Couse et al. 2001).
EDCs can also act through mechanisms independent of nuclear receptors, interacting with
nonsteroid receptors and coactivators in the transcriptional complex, as well as participating in
steroid synthesis and metabolism pathways (Tabb and Blumberg 2006). For example, a study
using a rat model demonstrated that 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (the
metabolite of DDT) increases the transcriptional activity of steroid and xenobiotic
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receptor/rodent pregnane X receptor and constitutive androstane receptor, two nuclear
receptors that are important to regulate hormone metabolism (Wyde et al. 2003).
Other mechanisms include direct impact on gene expression profiles during development
and alterations of DNA methylation, both causing transgenerational effects (Anway and Skinner
2008; Moral et al. 2008). Prenatal exposure to BPA in rats alters the mammary glands
morphology, changing the number of undifferentiated epithelial structures. Moreover, it also
modifies the expression of genes at different ages, such as down-regulation of Gad1, a gene
involved in cell communication, and up-regulation of several immune system genes like Cd3d and
Slpi (Moral et al. 2008). Fetal BPA exposure triggers changes in methylated genomic DNA and
alters gene expression patterns in postnatal and adult mammary glands, resulting in elevated
level of histone methylation at the promotor region of the alpha-lactalbumin gene (Dhimolea et
al. 2014).
1.2.1.3 Heavy metals
Heavy metals, such as arsenic, cadmium, lead, mercury, nickel, cesium, chromium and
copper, naturally exist as components of earth’s crust. Because of their non-biodegradable
characteristics, heavy metals can persist in the environment for a long time, therefore they are
widespread in air, soil, and water. Heavy metal-based consumer products including paint, glasses,
ceramics, cosmetics, toys, certain spices, contaminated food, tobacco and cigarettes, are all
considered potential sources of heavy metal exposure (CDC 2002; Meyer et al. 2008; Sainio et al.
2000; Woolf and Woolf 2005). Heavy metals are relatively poorly absorbed in the body; however,
once absorbed, they accumulate in the body resulting in the disruption of normal cellular
processes.
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The adverse health effects of heavy metals are attributed to both their ability to generate
free radicals leading to DNA damage, lipid peroxidation, and depletion of protein sulfhydryls
(Valko et al. 2005), and the ability to substitute polyvalent cations such as zinc, calcium, copper
and magnesium that are important for regulatory and enzymatic function in cells, including
mediators in catalysis, charge carriers, as well as basic structural components of protein complex
(Kampa and Castanas 2008). Cadmium is able to utilize the transport mechanisms developed for
calcium, iron and magnesium, influencing the homeostasis of these essential metals (Jihen el et
al. 2009). Based on this benefit, cadmium can be retained at a high concentration in smooth
muscle cells, resulting in interrupted calcium cation flux as well as cytotoxic effects (Abu-Hayyeh
et al. 2001; Prozialeck et al. 2008). As one of calcium-like metals, lead can compete with calcium
for transport across cellular membranes, including endoplasmic reticulum and mitochondria
membrane, leading to abnormal changes in cytosolic calcium ions (Alissa and Ferns 2011;
Goldstein 1993).
1.2.2

Diseases associated with environmental pollutants
The toxicity of a chemical is related to its concentration as well as individual susceptibility.

Thus, the presence of an environmental chemical in a person’s blood and urine does not
necessarily mean it is causing adverse effects on human health. However, a variety of
epidemiological data has revealed that human exposure to environmental pollutants is
associated with a wide range of diseases, including allergic diseases, arthritis and inflammatory
diseases, autoimmune diseases, diabetes, neurodegenerative disorders such as Parkinson’s
disease, reproductive function disorders such as testicular dysgenesis syndrome, polycyctic
ovary syndrome, premature ovarian failure, as well as cancers.
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1.3

Polycyclic aromatic hydrocarbon: 2-naphthol (2-NAP)

1.3.1 Polycyclic aromatic hydrocarbons
Polycyclic aromatic hydrocarbons (PAHs) are a family of organic chemicals which contain
two or more fused aromatic (benzene) rings. The conjoined benzene rings are the basic PAH,
which are also called the parent or unsubstituted PAHs. The derivatives or substituted PAHs
contain substituted groups, such as nitrogen, sulfur, oxygen atoms, or alkyl chains, on exterior
carbon atoms (Boehm 2006).
Based on the number of aromatic rings, PAHs can be simply divided into two groups: the
low-molecular-weight PAHs consisting of two to three rings, and the high-molecular-weight
compounds with four or more fused benzene rings (Law et al. 2002). Low-molecular-weight PAHs
are most likely to exist in the air and are biodegradable (Law et al. 2002), whereas high-molecularweight PAHs tend to exist in soils and sediments (Abbondanzi et al. 2005; Manoli and Samara
1999), thus persisting for a longer time in the environment.
1.3.1.1 Exposure sources to human
PAHs are ubiquitous environmental contaminants formed naturally or anthropogenically.
Naturally-occurring PAHs are mainly from wildfires, volcanic eruptions, and thermal geological
reactions (Maliszewska-Kordybach 1999), as well as from aromatization reactions that occurred
in microorganisms and non-biological chemical processes (Boehm 2006). Anthropogenic PAHs
result from incomplete combustion of organic matters. Fossil fuels, coal, wood, tobacco products,
heating and power generation, industry waste, and fuel-based transportation, especially car
emissions, are important sources of anthropogenic PAHs (ATSDR 1995). Indoor sources of PAHs
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include incomplete combustion of fuels or natural gas for heating and cooking, tobacco related
activities, burning of candles and incense, and overcooked food and grilled meat (ATSDR 1995).
PAHs are distributed widely in the environment including air, groundwater, drinking
water, soil, sediments, rain, snow and fog. PAHs in water, air and soil have been detected as a
mixture of compounds (Gan et al. 2009). Humans are exposed to PAHs mainly through air,
drinking water, food, and to a lesser extent, through skin contact.
1.3.1.2 Metabolism of PAHs in the body
PAHs are relatively inert, and can be stored and accumulated in fat cells, livers and kidneys
(Laher et al. 1984; Shu and Nichols 1979), but also can be metabolized. PAHs are primarily
metabolized in liver (Kapitulnik et al. 1977; Kiefer et al. 1988; Monteith et al. 1987), and secondly
in kidneys, but other organs, such as small intestines, thyroid, skin, lungs, and testes, are also
able to metabolize PAHs (ATSDR 1995). In general, PAHs first bind to aromatic hydrocarbon
receptors to activate phase I metabolic enzymes, e.g. cytochrome P450 enzymes (CYP). In the
first step of PAH metabolism, CYPs oxidize PAHs into unstable and electrophilic intermediates,
such as dihydrodiols, diol-epoxide, ortho-quinones, and radical cations. In the second step, these
electrophilic intermediates can be further conjugated with cellular thiols, glutathione, sulfate,
glucuronic acid, cysteine, or glycine by phase II conjugating enzymes, leading to the generation
of hydrophilic metabolites. Finally, these water-soluble conjugates and hydroxylated metabolites
are excreted from the body through feces and urine (Ramesh et al. 2004; Shimada 2006).
1.3.2

Health effects of PAHs
Once having been metabolically activated via xenobiotic-metabolizing enzymes, PAHs

exert their adverse health effects on genetic materials and genetic processes including DNA
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damage, DNA repair, mitosis and cell proliferation (ATSDR 1995). It has been reported by many
studies in vivo and in vitro that both individual PAHs and PAH mixtures show a wide range of
genotoxic effects including gene mutations, chromosome aberrations, sister chromatid
exchange, and elevated level of induced DNA adducts (ATSDR 1995; Denissenko et al. 1996). PAHs
are considered potential carcinogens. Studies using animal models have demonstrated the
carcinogenicity

of

seven

Benzo[b]fluoranthene,

PAHs,

including

Benzo[k]fluoranthene,

Benzo[a]pyrene,

Chrysene,

Benz[a]anthracene,

Dibenz[a,h]anthracene,

and

Indeno[1,2,3-cd]pyrene (Nisbet and LaGoy 1992). Moreover, PAHs are also known to be
immunotoxic. Benzo[a]pyrene is able to suppress humoral and cellular immune responses by
inhibiting the activation of B/T lymphocytes in vitro (Davila et al. 1996; Romero et al. 1997).
Prenatal exposure to a PAH mixture during gestation leads to increased weight and fat mass,
higher expression of adipose genes, such as peroxisome proliferator-activated receptor γ and
CCAAT/enhancer-binding proteins α, and lower DNA methylation of peroxisome proliferatoractivated receptor γ in offspring and grand-offspring mice, indicating the impact of PAHs
exposure on obesity and epigenetic changes in progeny (Yan et al. 2014).
1.3.3 2-NAP as an endocrine disruptor
2-Naphthol (2-NAP), or β-naphthol, (other names as 2-Hydroxynaphthalene; 2Naphthalenol; Naphth-2-ol), is one of the important metabolites of naphthalene, which is the
simplest PAH and contains two benzene rings. Urinary 2-NAP, as well as the other naphthalene
metabolites 1-naphthol (1-NAP), have been used as a biomarker of PAH exposure, especially as
a naphthalene biomarker.

10

Sharing the basic phenolic structure with endogenous steroid hormones, 2-NAP is
considered a potential endocrine disruptor. Schultz and Sinks (Schultz and Sinks 2002) detected
the estrogenic activity of 2-NAP to human estrogen receptor α (hERα) using the Saccharomyces
cerevisiae-based Lac-Z reporter assay. In addition, Terasaki (Terasaki et al. 2007) demonstrated
that 2-NAP is able to interact with hERα, and the relative affinity to 17β-estradiol for 2-NAP is
0.0009% using yeast two-hybrid assays, thus indicating the estrogenic agonist activity of 2-NAP.
Moreover, an epidemiological study with excessive PC game room users among young male
Koreans, who were exposed to abnormal level of PAHs, shows significantly negative correlation
between urinary 2-NAP and plasma testosterone concentrations, indicating an adverse impact
on male hormone homeostasis (Kim et al. 2005). Furthermore, in another in vitro study, Sun’s
group generated an expression vector by fusing the ligand binding domain of human thyroid
hormone receptor β (hTRβ1) with the DNA binding domain of Gal4. By transfecting this
expression vector to a Gal4-responsive luciferase reporter system, they showed that treatment
with 2-NAP inhibited the transcriptional activation of hTRβ1 induced by triiodothyronine (T3)
(Sun et al. 2008). This in vitro study reveals the thyroid hormone antagonist activity of 2-NAP.

1.4

Heavy metal: lead (Pb)

1.4.1 Lead exposure in the human population
Lead, both in organic and inorganic forms, is exposed to humans primarily through the
ingestion of contaminated food and water, inhalation of polluted air, and to a lesser extent via
dermal contact. 30-40% of inhaled lead is absorbed into the blood stream via the respiratory
tract. An average 10-15% of ingested lead is absorbed through the gastrointestinal tract in adults,
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and up to 50% in infants and young children (Markowitz 2000; Philip and Gerson 1994). Absorbed
lead accumulates in blood, soft tissues and bone. The estimated half-life of lead in these three
compartments are 35 days, 40 days, and 20 to 30 years, respectively (ATSDR 2007). More than
95% of the total body burden of lead is stored in skeletal bone and teeth. Once absorbed, lead
excretion from the body is extremely slow and occurs mainly through the urine (Philip and Gerson
1994).
Lead has been present in human environments for over 5000 years (Philip and Gerson
1994). The use of lead in human activities can be traced back to ancient Rome as a component
of water pipes. In modern times, lead was used in paint, and in the 20 th century in gasoline to
improve their performance. However, these two applications of lead were banned in 1977 and
1990, respectively, due to health concerns. Nowadays, lead is still used in a wide variety of
products such as batteries, cosmetics, ceramic glazes, and certain imported home remedies
(ATSDR 2007).
Because of its wide distribution, exposure of humans to lead is inevitable. Leaded paint
that remain in old houses built before 1978 and lead-contaminated house dusts are the major
sources of lead exposure to children in the United States. Drinking water is contaminated by lead
through corrosion of plumbing pipes, faucets and solder, especially in homes built before 1986
which are at higher risk of water contamination from lead plumbing materials. Food and
beverages might be contaminated with lead during production, processing, packaging, and
storage. Even its inclusion is prohibited in many products, lead is still used in commercial
products, such as painted toys, furniture, toy jewelry, cosmetics, food and liquid containers, and
plumbing materials (ATSDR 2007).
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1.4.2 Health effects and mechanisms of lead toxicity
Based on the most recent report from the CDC, the geometric mean of lead concentration
in blood has decreased to 1.12 μg/dL for the US population from NHNES 2009-2010 (CDC 2015),
compared with more than 10 μg/dL in the 1970s (Mahaffey et al. 1982). The average blood lead
level has declined, but the low exposure of lead during development and throughout the lifetime
remains as a serious health issue.
In general, lead affects every system in the body. Children are the most vulnerable
population to environmental lead exposure because of the high rate of absorption and retention
as well as the routes and frequency of lead exposure. In children, presence of lead in blood is
associated with a decrease in the intelligence quotient-IQ, impaired peripheral nerve function,
decreased hearing acuity, and increased attention deficit hyperactivity disorder (ATSDR 2007). In
the adult population, chronic exposure to low levels of lead results in adverse health effects on
erythropoiesis, blood pressure, kidney function, and the central nervous system (Tchounwou et
al. 2012).
The mechanisms at the basis of lead toxic effects are not fully characterized, but the
abilities to 1) compete with or substitute for essential metallic cations such as calcium and zinc,
2) promote reactive oxygen species production and free radicals formation, and 3) directly
interact with proteins such as sulfhydryl, carboxyl groups, phosphate, and amine are considered
the major mechanisms of lead toxicity (ATSDR 2007; Flora et al. 2007; Hermes-Lima et al. 1991;
Tchounwou et al. 2012). In addition, long term exposure to lead is demonstrated to reduce global
DNA methylation of long interspersed nuclear elements-1, indicating epigenetic effects of lead
exposure (Li et al. 2013; Wright et al. 2010).
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1.5

Obesity: a pandemic disease
Obesity is an increasing problem all over the world. According to the World Health

Organization’s (WHO) global estimates, more than 600 million adults were obese, and 1.9 billion
adults (39% of global population) were overweight in 2014. Childhood obesity is of particular
concern. The WHO estimates that in 2013, 42 million of 0- to 5-year-old children were overweight
or obese, with childhood obesity 30% higher in developing countries than in developed countries
(WHO 2015). In the United States, more than 65% of adults are overweight or obese and 6.4%
are extremely obese with body mass index (BMI) over 40 kg/m2. Among children and adolescents
aged from 2 to 19 years, 31.8% of them are overweight or obese, and 8.4% of 2- to 5-year-olds,
17.7% or 6- to 11-year-olds, and 20.5% of 12- to 19-year-olds are obese (Ogden et al. 2014).
Obesity is a medical condition where excessive body fat accumulates to an extent that
causes adverse effects on health, with increasing risk of morbidity and mortality. In obese tissue,
low-grade and chronic inflammation causes insulin resistance, which links obesity to multiple
metabolic diseases including type 2 diabetes, cardiovascular diseases, autoimmune diseases,
osteoarthritis, respiratory problems, nonalcoholic fatty liver dysfunction, and increased risk for
cancer and cancer-related mortality (Collins 2005; Mokdad et al. 1999; Mokdad et al. 2003).
Obesity is caused by a complex interaction of multiple factors, such as genetic, behavioral
and environmental, acting through psychological mediators that interrupt energy homeostasis.
On one hand, genetic influences play a role through susceptibility genes, which increase the risk
of developing a disease. Studies from monogenic animal models, as well as from rare obesityassociated syndromes with a familial inheritance, indicate the consistent link between obesity
and single-gene disorders. On the other hand, different physical activity/exercise habits and
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metabolic rate reveal a direct association between low energy expenditure and
overweight/obesity. In addition, increased energy intake by a high calorie, high fatty diet and
sedentary lifestyle represent root causes for the prevalence of overweight and obesity
(Kopelman 2000). Although genetic/epigenetic influences are undoubtedly important, one of the
most plausible explanations for the rapid increase in obesity over the past 50 years is the adverse
effects of environmental pollutant exposure, in combination with unhealthy diet and lifestyle.

1.6

Antimicrobial peptides and adipocytes

1.6.1 AMP definition and origin
The host immune response of living organisms against pathogens and microbial infections
involves the cooperation of cells in the innate and adaptive immunity. The production of
antimicrobial peptides (AMPs) by resident cells during the lag phase between the onset of
infections and the recruitment of additional leukocytes immediately protects the host organisms.
This immediate antimicrobial response occurs within several minutes, thus serving as the firstline of host defense (Wiesner and Vilcinskas 2010).
AMPs are a group of small peptides and proteins that have direct antimicrobial activity;
therefore, the production of AMPs is considered as the most ancient mechanism of host defense.
AMPs are produced by almost all species, including bacteria, plants, insects, invertebrates,
vertebrates, and mammals. Most AMPs exhibit a wide-spectrum of microbicidal activity to kill or
neutralize bacteria, viruses, fungi, and parasites. AMPs are present in the skin, eye, mucosal
surfaces of the respiratory system and the digestive system, bone marrow, and testes (Hancock
and Scott 2000). Their expression can be either constitutive or inducible in different cell types,
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such as epithelial cells, keratinocytes, Paneth cells, neutrophils, macrophages, monocytes, mast
cells, as well as other leukocytes (Hancock and Scott 2000).
AMPs are small peptides that are encoded by the genome and synthesized by ribosomes.
Eukaryotic AMPs usually comprise between 12 and 50 amino acids with no unusual posttranscriptional modifications (Wiesner and Vilcinskas 2010). Most of the eukaryotic AMPs exert
wide-spectrum activity at high concentrations, while certain AMPs display a very restricted
spectrum. Beside the direct antimicirobial activities, AMPs exert other biological functions such
as recruiting neutrophils and macrophages, modulating cytokine production in leukocytes (De
Yang et al. 2000; Huang et al. 1997), and promoting re-epithelialization (Tokumaru et al. 2005).
To date, the Antimicrobial Peptide Database (APD, http://aps.unmc.edu/AP/main.php) has
reported more than 2600 AMPs from different organisms.
1.6.2 Groups and mechanisms of action
On the basis of their molecular targets, structures, peptide properties (e.g., net charge),
and sources, AMP can be categorized in different groups. However, three major groups are
usually considered. The first group includes AMPs characterized on the basis of their biological
function (antibacterial peptides, antiviral peptides, antifungal peptides, antiparasitic peptides,
anticancer peptides, anti-protist peptides, insecticidal peptides, spermicidal peptides,
chemotactic peptides, would healing, antioxidant peptides, and protease inhibitors) (Hancock
and Sahl 2006). The second group includes AMPs characterized on the basis of amino acid
composition and three-dimensional structure, and consists of four classes: (1) α-helix structures,
(2) β-sheet structures with disulfide bonds, (3) structures with both α-helix and β-strands, and
(4) structures with neither α-helix or β-strands (Lai and Gallo 2009). The third group, recently
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introduced, is defined on the basis of, a universal classification that takes into account the
peptide bonding patterns: class I linear AMPs such as human cathelicidin, class II sidechainconnected peptides such as the human defensin family, class III polypeptides with side chain
linked to the backbone (e.g., lassos), and class IV loop peptides such as cyclic defensins found in
rhesus macaques (Wang 2015).
The mechanisms of action of AMPs have not been fully characterized, but different
mechanisms of action for cationic AMPs directed against Gram-negative bacteria have been
proposed. According to one of the proposed mechanisms, the positively charged AMPs adsorb
onto negatively charged bacterial surfaces by electrostatic attraction, whereas, according to
another, the amphipathic structures allow AMPs to aggregate or integrate into the lipid bilayer.
In addition, the barrel-stave model (Rosado et al. 2008), worm-hole model (Yang et al. 2001), and
the carpet model (Chang et al. 2008) have been proposed to explain how AMPs form pores and
disrupt bacterial cell membranes (Wiesner and Vilcinskas 2010)). The insertion of AMPs into lipid
bilayers finally leads to cell lysis and the loss of ion gradients and essential metabolites, eventually
causing cell death.
1.6.3 Role of adipocytes in immunity
The adipose tissue is increasingly considered as an immunological active organ because
of the presence of a variety of immune cells and the production of adipokines and pro- or antiinflammatory cytokines and chemokines by mature adipocytes (Grant and Dixit 2015).
Adipocytes, by secreting adipokines (adipocytokines), cytokines and chemokines, crosstalk with immune cells and modulate their functions (Ouchi et al. 2011). On one hand, adipocytes
interact with a variety of immune cells. It has been well established in animal models of obesity
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that excessive mature adipocytes recruit neutrophils (Elgazar-Carmon et al. 2008), macrophages
(Weisberg et al. 2003), and lymphocytes (Nishimura et al. 2009; Winer et al. 2011) into adipose
tissue. In addition, mature adipocytes are able to mimic antigen presenting cells to promote T
lymphocytes activation and proliferation. This action requires a direct contact through Major
Histocompatibility Complex (MHC) class II molecules expressed on adipocytes as well as
adipocyte-secreted pro-inflammatory cytokines (Poloni et al. 2015). On the other hand,
adipokines, produced by mainly by adipocytes, regulate immune responses. Leptin induces the
production of TNF-α, IL-6, and IL12 in CD4 T cells promoting pro-inflammatory immune responses
(Loffreda et al. 1998). Adiponectin, on the other hand, plays an anti-inflammatory role in
macrophages by suppressing the activation of NFκB and TNF-α and IL-6 induction by LPS (Ajuwon
and Spurlock 2005; Wulster-Radcliffe et al. 2004). Resistin, involved in glucose metabolism and
insulin sensitivity, modulate inflammatory responses by upregulating the expression of adhesion
molecules VCAM-1 and ICAM-1 on vascular endothelial cell surfaces (Kawanami et al. 2004).
A recent study focusing on skin infection by Staphylococcus aureus reveals one additional
role of adipocytes in innate immunity: bacteria-induced differentiating adipocytes protect the
animals by producing cathelicidin that directly kill the pathogens (Zhang et al. 2015). This study
elucidates important properties of adipocyte at the site of infection. Firstly, presence of bacteria
can induce preadipocytes to differentiate. Secondly, upon stimulation, adipocytes are capable of
producing cathelicidin, but this response only appears in the differentiating adipocytes, not the
fully mature adipocytes.
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1.7

Adipocyte differentiation
In adipose tissue, mature adipocytes take up approximately one-third of the cellular

composition. The remaining two-thirds are connective tissue, nerve tissue, endothelial precursor
cells, mesenchymal stem cells, preadipocytes in different differentiating stages, and immune cells
(e.g., T regulatory cells and macrophages) (Hassan et al. 2012). Mature adipocytes (also named
fat cells or lipocytes) are capable of storing energy in the form of lipid, while preadipocytes,
serving as the precursors, have the ability to differentiate into mature adipocytes.
1.7.1 Adipogenesis is a multiple-stage event
Adipogenesis is a process in which mesenchymal precursors commit to the adipose
lineage and develop into mature adipocytes (Fig. 1.1). This process occurs in several stages
including committed preadipocyte, mitotic clonal expansion, terminal differentiation and mature
adipocyte. Mesenchymal precursors have the ability to differentiate into multiple lineages, i.e.,
adipocytes, myocytes, chondrocytes, and osteocytes (Covas et al. 2008; Huang et al. 2009; Lin et
al. 2010). Upon appropriate stimulation, these precursors commit to differentiate along the
adipocyte lineage and become fibroblast committed preadipocytes. After exposure to hormonal
stimulation, the G1-growth-arrested preadipocytes immediately reenter the cell cycle and
undergo several rounds of cell division, a prerequisite phase for differentiation often referred as
mitotic clonal expansion. During mitotic clonal expansion, the stimulated preadipocytes express
cell cycle regulators as well as specific adipogenic transcriptional regulators such as CCAATenhancer-binding protein-β and δ (C/EBPβ and C/EBPδ). Following this event, the stimulated cells
undergo terminal differentiation in which activation of the transcriptional regulator peroxisome
proliferator-activated receptor-γ (PPARγ) and C/EBPα results in expression of adipocyte genes
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that involve in fatty acid synthesis, lipid metabolism, as well as adipokine production. At the end
of terminal differentiation stage, fibroblast preadipocytes become large spherical lipid-producing
adipocyte (Lefterova and Lazar 2009).

Figure 1.1 Scheme of different stages of adipogenesis in 3T3-L1 cells.
After adding adipogenic stimulators, post-confluent 3T3-L1 preadipocytes re-enter the cell cycle, a stage
called mitotic clonal expansion. During this two-three-round proliferation, early transcriptional factors
C/EBPβ and C/EBPδ are activated, which together initiate the activation of two master transcriptional
regulators of adipogenesis, C/EBPα and PPARγ. C/EBPα and PPARγ function in the terminal differentiation
stage to regulate the expression of a variety of adipocyte-specific genes such as adiponectin, aP2, glucose
transporters, leading to the conversion of preadipocytes to mature adipocytes.
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1.7.2 The transcriptional cascade of adipogenesis
Adipocyte differentiation is a multi-step process involved in a sequential transcriptionalfactor-activation cascade regulating cell cycle proteins and adipogenic gene expression (Tang and
Lane 2012). Immediately after induction, the activation and phosphorylation of cyclic AMP
response element-binding protein (CREB) initiate the expression of C/EBPβ (Davis and Zur Nieden
2008; Zhang et al. 2004). During mitotic clone expansion, C/EBPβ and C/EBPδ are the first two
activated transcriptional factors. The expression of C/EBPβ and C/EBPδ can be detected within 4
hours post induction; however, these two transcriptional regulators become functionally active
after 16 hours post induction (Tang and Lane 1999). The acquisition of DNA-binding ability by
C/EBPβ is achieved via sequential phosphorylation (Tang et al. 2005). Later, dual phosphorylated
C/EBPβ, in combination with C/EBPδ, regulates the expression of C/EBPα and PPARγ, two master
transcriptional regulators of adipogenesis, by binding to C/EBP regulatory elements in their
proximal promoters, initiating the terminal differentiation stage (Cao et al. 1991; Wu et al. 1995;
Wu et al. 1996; Yeh et al. 1995). C/EBPα and PPARγ function together as activators regulating a
large group of adipocyte genes, such as fatty acid binding protein 4 (FABP4, also known as aP2),
insulin receptor substrate (IRS) and GLUT4 (Rosen and MacDougald 2006). PPARγ is both
necessary and sufficient for adipocyte formation (Rosen et al. 1999), whereas C/EBPα is a robust
driver of adipogenesis and is required for maintaining the expression of PPARγ. Though C/EBPα
cannot induce adipocyte differentiation in the absence of PPARγ, it is crucial for controlling insulin
action such as insulin-dependent glucose uptake (Rosen et al. 2002; Wu et al. 1999).
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1.7.3 Other factors that control adipogenesis
Hormones and extracellular factors directly control adipogenesis upstream of
transcriptional regulators. Among these secreted proteins and factors, insulin is a well-studied
inducer of adipocyte differentiation. Insulin and insulin-like growth factors (IGF) act through the
insulin receptor and the IGF-1 receptor on the cell membrane to initiate the insulin/IGF-1
signaling pathway. Autophosphorylation of tyrosine residues in the insulin/IGF-1 receptor
activates its intrinsic tyrosine kinase to recruit and phosphorylate insulin receptor substrate-1/2
(IRS-1/2), which further attracts various adaptor proteins. The insulin signaling pathway for
adipogenesis involves two downstream kinase systems, the phosphatidylinositol 3-kinaseprotein kinase B/Akt (PI3K/Akt) pathway (Inoue et al. 1998; Saad et al. 1994) and the MAP kinases
(Boney et al. 2000). Akt serves as a crucial effector of insulin-induced adipogenesis. The
phosphorylation of Akt suppresses the anti-adipogenic Forkhead Box O1 (FOXO1), leading cells
to re-enter the cell cycle (Tong et al. 2000; Tong et al. 2005; Yun et al. 2008). PI3K/Akt also
modulates the activation of the pro-adipogenic cyclic AMP response element-binding protein
(CREB) and GSK3β, which further promotes C/EBPβ expression and phosphorylation (Tang et al.
2005; Zhang et al. 2004). Furthermore, it regulates PPARγ and sterol responsive element binding
protein 1 (SREBP1) through the active mammalian target of rapamycin (mTOR) complex (Yu et al.
2008).
The role of MAP kinase system in adipogenesis is not clear, and contradictory roles of ERK
1/2 have been reported. Phosphorylation on Thr188 of C/EBPβ first occurs by MAP/ERK1/2 within
two hours after induction. Later, glycogen synthase kinase 3β (GSK3β) comes in and
phosphorylates the second site on Thr179 or Ser184 about 12 to 14 h after induction, allowing
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its eventual transactivation of C/EBPα and PPARγ (Tang et al. 2005; Tang and Lane 1999).
Conversely, sustained ERK 1 activation during the terminal differentiation phase leads to
decreased PPARγ activity (Bost et al. 2005). These conflicting results indicate that the function of
MAP/ERK in adipogenesis is time restricted, which is necessary during early stages of
differentiation but inhibitory in the terminal stage.
1.7.4 Mouse 3T3-L1 preadipocyte Model
Mouse 3T3-L1 preadipocytes are a widely used and well-studied in vitro cell model for
adipocytes and obesity-related research. This cell line was isolated from 17-19-day-old Swiss
mouse embryonic tissue in Green’s laboratory and characterized by its indefinite and
homogenous cellular population (Green and Kehinde 1974; Green and Meuth 1974; Green and
Kehinde 1975). Based on its faithful recapitulation of the adipogenic transcriptional cascade, 3T3L1 preadipocytes become a complementary tool to animal models for investigating adipocyte
differentiation.
3T3-L1 preadipocytes can be induced to differentiate into mature adipocytes by a
standard differentiation cocktail, which includes 3-isobutyl-1-methylxanthine (IBMX),
dexamethasone (DEX) and insulin. The addition of IBMX and DEX spontaneously activates C/EBPβ
and C/EBPδ by stimulating cAMP accumulation and activating CREB (Cao et al. 1991; Gonzalez
and Montminy 1989; Reusch et al. 2000). The presence of insulin accelerates the differentiation
process by activating the PI3K/Akt pathway. In the standard differentiation protocol, postconfluent 3T3-L1 preadipocytes are stimulated with the differentiation medium in the presence
of bovine serum on day 0, and the differentiation medium is replaced on day 3 with the basic
culture medium containing insulin alone. Cells are maintained in this insulin medium until day 8.
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1.8

Research overview
Many environmental pollutants are considered to be obesogens. The adipogenic

properties of some environmental pollutants, such as BPA, PCBs, and DDT, have already been
demonstrated in vitro and in vivo (Schug et al. 2011). Epidemiological studies indicate that PAHs
and the heavy metal lead are associated with obesity, but no clear and direct evidence is currently
available to confirm their adipogenic activity.
Adipocytes play multiple roles in regulating immune functions. Mature adipocytes secrete
adipokines to promote inflammation, recruit leukocytes, and modify lymphocyte functions
(Loffreda et al. 1998). Differentiating adipocytes produce the antimicrobial peptide cathelicidin
to modulate innate immunity (Zhang et al. 2015). Several environmental pollutants exhibit a
modulatory role on mature adipocyte function as it relates to adipokine production (Valentino et
al. 2013). The effect of environmental pollutants on antimicrobial peptide production in
adipocytes has not yet been studied.
The major goal of the present dissertation is to characterize the potential obesogenic
effects of 2-NAP and lead, and their ability to induce antimicrobial peptide production, by using
the mouse 3T3-L1 preadipocytes model. By exposing 3T3-L1 cells to 2-NAP and lead, we have
shown that:
(a) 2-NAP accelerates 3T3-L1 differentiation in a dose-dependent manner
(Chapter 2);
(b) Lead is capable of upregulating 3T3-L1 adipogenesis. However, the dose effects
are non-monotonic (Chapter 3);
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(c) The effect of lead at higher doses attenuates the 2-NAP effect on adipogenesis
(Chapter 4);
(d) 2-NAP and lead modulate catheliicdin production (Chapter 5).
Therefore, we demonstrate the adipogenic properties of 2-NAP and lead, and the co-modulatory
effects of 2-NAP and lead on adipogenesis.
Environmental pollutants are epidemiologically associated with a variety of adverse
health effects, including obesity and dysregulated immune responses. The characterization of the
direct modulatory roles and co-effects of environmental pollutants during adipocyte
differentiation will help to define the environmental causes of the obesity and inflammation
pandemic.
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2

Chapter 2: The polycyclic Aromatic Hydrocarbon 2-Naphthol Contributes to Adipocyte
Differentiation in the Mouse 3T3-L1 Model

2.1

Summary
Polycyclic aromatic hydrocarbons (PAHs) are a family of chemicals generated by the

incomplete combustion of coal, oil, and gas. Once in the body, PAHs accumulate in fat tissue,
liver, and spleen. The presence of low-molecular-weight PAHs metabolites in the urine is
associated with a higher body mass index and with obesity in children 6-11 years old. In
particular, 2-naphthol (2-NAP), the major metabolite of the PAH naphthalene, is positively
associated with childhood obesity. Thus, we hypothesized that 2-NAP induces the differentiation
of pre-adipocytes to adipocytes.
To test our hypothesis, we used an in vitro model consisting of mouse 3T3-L1
preadipocytes. This cell line can be induced to differentiate into mature adipocytes using a
standard differentiation protocol, which includes exposure of the 3T3-L1 cells to 3-isobutyl-1methylxanthine (IBMX), dexamethasone (DEX) and insulin for the first three days, followed by
insulin alone for six days. In our study, 3T3-L1 cells were exposed to six ten-fold concentrations
of 2-NAP (100 pM to 10 μM) in two experimental protocols. In the first experimental protocol
(Insulin+2-NAP D3-8), cells were induced by the standard differentiation medium with IBMX, DEX,
and insulin for three days followed by insulin and 2-NAP for six days. In the second experimental
protocol (2-NAP D0-8), cells were induced by IBMX, DEX, and 2-NAP for three days followed by
2-NAP alone for six days. Terminal differentiation was evaluated by cell morphology, lipid
production, and expression levels of three marker genes of adipogenesis: C/EBPα, PPARγ, and
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aP2. The early transcriptional cascade was evaluated by assessing the gene expression levels of
the early transcriptional factor C/EBPβ, the insulin signaling molecule IRS2, and the insulinregulated transcriptional factor SREBP1c.
Results from both experiments show that 2-NAP-treated 3T3-L1 cells differentiated from
fibroblast cells into mature lipid-producing spherical adipocytes and accumulated a higher level
of lipids in comparison to cells treated with the basic DMEM medium. In the Insulin+2-NAP D3-8
experiment, in presence of insulin, 2-NAP elevated the mRNA level of two major transcriptional
regulators of terminal adipocyte differentiation C/EBPα and PPARγ, and the mature adipocytespecific gene aP2, in a dose-dependent manner. In the 2-NAP D0-8 experiment, in the absence of
insulin, C/EBPα, PPARγ, and aP2 were also activated in 2-NAP-treated 3T3-L1 cells. In cells treated
with higher concentrations, the activation fold of C/EBPα and PPARγ was as high as in cells
treated with the standard differentiation protocol. Results from the transcriptional cascade of
adipocyte differentiation revealed that during the early differentiation phase (day 0-3), 2-NAP
increased C/EBPβ, IRS2, and SREBP1c expression levels similarly to those seen in the 2-NAP D0-8
experiment, compared to those induced by insulin in the standard differentiation protocol.
Together, these results indicated that 2-NAP is capable of inducing adipocyte
differentiation of 3T3-L1 cells. 2-NAP contributes to adipocyte differentiation by regulating
transcriptional regulators of adipocyte differentiation and molecules involved in insulin signaling
pathway. Therefore, 2-NAP plays a potential role in interrupting lipid homeostasis, possibly
leading to obesity and associated disorders.
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2.2

Introduction
Childhood obesity can be associated with many adverse health outcomes in adulthood

(Freedman et al. 2007). The causes of childhood obesity have been widely studied over the past
couple decades. One emerging hypothesis is that the exposure of ubiquitous environmental
chemicals may effect childhood growth (Newbold 2010). In particular, the exposure of
environmental endocrine disrupting chemicals is an important factor for childhood obesity.
A recent study by researchers at the Centers for Disease Control and Prevention, has
found that urinary low-molecular-weight PAH metabolites are associated with higher body mass
index and obesity in younger children (6-11 years old). Specifically, 2-NAP, the major metabolite
of naphthalene, is found to be positively associated with childhood obesity, indicating its
potential role in fat cell formation and obesity (Scinicariello and Buser 2014). As an endocrine
disruptor, the question of whether 2-NAP is capable to induce adipocyte formation (also known
as adipogenesis) and lipid homeostasis has not been answered.
Therefore, in this study, we aimed to investigate the effect of 2-NAP on adipocyte
differentiation and lipid homeostasis in vitro. Mouse 3T3-L1 cells were initiated with
differentiation cocktail for 72 hours, then incubated with six ten-fold concentrations of 2-NAP
(100 pM to 10 μM). The terminal adipocyte differentiation was evaluated by lipid accumulation
using Oil Red O staining, and by evaluating the expression of CCAAT-enhancer-binding protein-α
and β (C/EBPα and C/EBPβ), peroxisome proliferator-activated receptor-γ (PPARγ), and fatty acid
binding protein 4 (FABP4, also known as aP2). The molecules involved in and regulated by the
insulin signaling pathway were also analyzed by determining the gene expression levels of the
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Insulin receptor substrate proteins (IRS) 2 and sterol responsive element binding protein (SREBP)
1c.

2.3

Materials and methods

2.3.1 Materials
Mouse embryo fibroblast 3T3-L1 cells (ATCC CL-173, lot 59796011) and bovine calf serum
(ATCC, 30-2030) were obtained from ATCC. Dulbecco’s modified Eagle’s medium (DMEM)
(Cellgro 10-013CV), 100X penicillin-streptomycin solution (Cellgro 30-002-CI) were purchased
from Mediatech, Inc. Human insulin solution (I9278), dexamethasone (D2915), 3-Isobutyl-1methylxanthine (I5879), formalin solution (HT501128), Oil Red O (O0625) were obtained from
Sigma-Aldrich Co. LLC. 2-Naphthol was purchased from Acros Organics.
2.3.2 Experimental design
Confluent 3T3-L1 preadipocytes can be induced to differentiate synchronously by using a
standard differentiation protocol with the most commonly used differentiation cocktail. This
cocktail contains 0.5 mM 3-isobutyl-1-methylxanthine (IBMX), 0.25 µM dexamethasone (DEX),
and 1 µg/mL insulin (Zebisch et al. 2012). After the first several hours, insulin alone is required to
continue the differentiation process (Caprio et al. 2007). This standard differentiation protocol,
as shown in Figure 2.1, was used as the positive control in our study. 3T3-L1 preadipocytes were
seeded (day -2) and cultured in the basic medium until 100% confluent. Post-confluent
preadipocytes were induced with the differentiation medium containing IBMX, DEX, and insulin
for three days (day 0 to day 3), during which 3T3-L1 cells underwent several cell cycles and
expressed the two early adipocyte transcriptional regulators C/EBPβ and C/EBPδ. On day 3, the
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differentiation medium was removed and replaced with the basic culture medium with 1 µg/mL
insulin. During the last six days (day 3 to day 8), the stimulated preadipocytes entered the
terminal differentiation phase and gradually became mature adipocytes.
Here in our study, we firstly replaced the insulin in the standard differentiation protocol
by 2-NAP (Experiment 2-NAP D0-8), and then exposed the cells to 2-NAP during the entire
experiment from day 0 to day 8 in order to compare the role of 2-NAP with that of insulin during
3T3-L1 adipogenesis. In the second experiment (Experiment Insulin+2-NAP D3-8) we stimulated
cells with the standard differentiation protocol, then added 2-NAP to the cells on day 3 and kept
it until day 8. This exposure protocol allowed us to evaluate the effect of 2-NAP on the terminal
differentiation phase of adipogenesis. We also designed the third experiment as comparison to
Experiment Insulin+2-NAP D3-8. In the third experiment (Experiment insulin+2-NAP D0-8), postconfluent cells were induced with the standard differentiation protocol. 2-NAP was added on day
0 and kept in the cell culture for the entire experiment (Fig.2.1).
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A. Positive control protocol

C. 2-NAP exposure protocols
1) Experiment 2-NAP D0-8

B. IBMX+DEX control protocol

2) Experiment Insulin+2-NAP D3-8

3) Experiment Insulin+2-NAP D0-8

Figure 2.1 Protocols for adipogenic differentiation and 2-naphthol exposure in 3T3-L1 cells.
Confluent cells were differentiated (designated as day 0, indicated by the first black arrow) by replacing
the basic DMEM medium with the desired differentiation media for three days, followed by addition of
the chemical containing media for six days. The concentrations of each component used where 0.5 mM
for IBMX, 0.25 μM for DEX, and 1 μg/mL for insulin. Differentiation media containing IBMX and DEX with
or without insulin were used for the positive control and IBMX+DEX control, respectively. In the 2-NAP
experiments, the differentiation medium containing IBMX, DEX, and 2-NAP was used for Experiment 2NAP D0-8 differentiation, whereas the differentiation medium containing IBMX, DEX, and insulin with or
without 2-NAP was used for insulin+2-NAP experiments. On Day 3 (indicated by the second black arrow),
differentiation media were changed to DMEM medium with 1 μg/mL insulin for the positive control; the
basic DMEM medium for the IBMX+DEX control; DMEM medium with 2-NAP for Experiment 2-NAP D0-8;
or DMEM medium with 1 μg/mL insulin and 2-NAP for Insulin+2-NAP experiments, respectively, until the
end of the experiments (day 3 to day 8). 2-NAP exposure period in each experiment was indicated by a
red curly bracket.
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2.3.3 Cell culture and differentiation
3T3-L1 cells were cultured in the DMEM medium supplemented with 10% bovine calf
serum (BCS), 100 I.U. penicillin and 100 μg/mL streptomycin. Cells were grown in 75 cm2 culture
flasks in a humidified atmosphere with 5% CO2 at 37 °C and subcultured when they became 80%
confluent. Cells were seeded at a density of 6x104 cells/well in Costar 6-well plates with the basic
DMEM medium. In the cell viability test, cells were seeded at 5000 cells/well in 96-well plates.
After reaching confluency (Day 0), cell differentiation was induced by replacing the basic DMEM
medium with differentiation media for three days (day 0 to day 2) followed by chemicalcontaining medium for six days. The concentrations of each component in the standard
differentiation cocktail were 0.5 mM for IBMX, 0.25 μM for DEX, and 1 μg/mL for insulin.
Differentiation media containing IBMX and DEX with or without insulin were used for the positive
control and the IBMX+DEX control, respectively. In the 2-NAP experiments, the differentiation
medium containing IBMX, DEX, and 2-NAP was used for Experiment 2-NAP D0-8 differentiation,
whereas the differentiation medium containing IBMX, DEX, and insulin with or without 2-NAP
was used for Insulin+2-NAP experiments. On Day 3, differentiation media were changed to
DMEM medium with 1 μg/mL insulin for the positive control; the basic DMEM medium for the
IBMX+DEX control; DMEM medium with 2-NAP for Experiment 2-NAP D0-8; or DMEM medium
with 1 μg/mL insulin and 2-NAP for the Insulin+2-NAP experiments, respectively, until the end of
experiments (day 3 to day 8). Six ten-fold concentrations of 2-NAP, 100 pM, 1 nM, 10 nM, 100
nM, 1 μM and 10 μM, were used in the first two experiments, while 1 nM, 100 nM, and 10 μM
were used for Experiment Insulin+2-NAP D0-8. 3T3-L1 cells maintained with the basic DMEM
medium were used as negative control.
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2.3.4 Oil Red O staining
On the termination day, adipocytes were stained with Oil Red O solution. Briefly, the
culture medium was gently and slowly removed from each well, and cells were washed twice
with 1X phosphate buffered saline (PBS). Cells were then fixed with 10% formalin solution at 4
°C overnight or longer. After formalin fixation, cells were washed with DI water twice and
incubated with 1.5 mL 60% isopropanol for 5 min at room temperature. After removal of
isopropanol, cells were completely dried at room temperature, then incubate with 1 mL Oil Red
O working solution for 30 min. Subsequently, cells were washed with DI water for three times,
dried and analyzed under the microscope. The Oil Red O working solution is stable for only 2
hours, so it was prepared freshly before use. Oil Red O stock was made by dissolving 300 mg Oil
Red O powder in 100 mL isopropanol (this stock is stable for one year). The working solution was
prepared as follow: Oil Red O stock was filtered by Whatman filter papers and diluted with DI
water at 3:2 ratio. After 10 min incubation, Oil Red O working solution was filtered with 0.22 μm
syringe filter.
Triglyceride droplets stained with Oil Red O were photographed under the microscope at
10X and 20X magnification. Lipid accumulation was quantified by measuring the absorbance at
490 nm using EnSpire multilabel plate reader (PerkinElmer) with well area scan mode (Program
setting parameters in Table 2.1). The absorbance was expressed as means ± standard error of 80
spots scanned for each sample.
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Table 2.1 Parameter settings for EnSpire multilabel plate reader.
Culture plate supplier

Plate Dimensions

Scan setting

Coring Life Sciences: Costar® 6 Well Clear TC-Treated Multiple Well Plates,
Bulk Packed, Sterile (Product #3506)
Wells
Column (mm)
Row (mm)
A1
24.76
23.16
A3
102.99
23.16
B1
24.76
62.28
B3
102.99
62.28
Number of horizontal points (X)
10
Number of vertical points (Y)
10
Distance between points (mm)
1.56
Scan mode
Round
Wavelength
490
Measurement height (mm)
7.5
Number of flashes
100

2.3.5 XTT assays
Cell viability was tested on the termination day of experiments by XTT assays. The XTT
assay measures the mitochondrial dehydrogenase activity in viable cells. The tetrazolium ring of
XTT salt can be reduced by mitochondrial dehydrogenase of living cells, resulting in a watersoluble orange formazan derivative. In brief, cells were seeded in 96-well plates and cultured
according to the experimental protocol mentioned above. On the termination day, the culture
medium was replaced by 100 μL freshly prepared XTT working solution. After 4-hour incubation
at 37 °C, the absorbance of orange formazan was measured at 450 nm and 690 nm with a BioTek microplate spectrophotometer. The results were presented as proliferation percentage of
the negative control and expressed as means ± standard error of triplicate samples.
2.3.6 Quantitative real-time reverse transcription-polymerase chain reaction (Real-Time
PCR)
Total RNA was extracted from cells using QIAGEN RNeasy Plus Mini Kit (Qiagen Inc.,
Valencia, CA). 5 μL, 7.5 μL and 10 μL of total RNA extracted on Day 8, Day 5, and Day 2 respectively
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was reverse transcribed into cDNA using High-Capacity cDNA reverse transcription kit (Applied
Biosystems). The reaction mixture contained 1x reverse transcriptase buffer, 4 mM dNTP
(deoxynucleotide triphosphate), 5x Random primers, 1 U RNase inhibitors, and 2.5 U of
MultiScribe Reverse Transcriptase. The RT-PCR was performed with the following cycle
parameters: 25°C for 10 min, 37°C for 120 min, and 85°C for 5 min. Synthesized cDNA was diluted
with RNase-free water. Then, quantitative real-time PCR amplification was performed with
appropriate sets of primers using Taqman gene expression assays in a total volume of 20 μL
containing aliquoted cDNA samples. The gene expression assays were carried out with the
following cycle parameters: 55°C for 2min; 94°C for 10 min; 40 cycles of 94°C for 15 sec and 60°C
for 60 sec. The primers and probes were obtained from Applied Biosystems: C/EBPα
(Mm00514283_s1),

C/EBPβ

(Mm00843434_s1),

PPARγ

(Mm01184322_m1),

aP2

(Mm00445878_m1), Irs2 (Mm03038438_m1), Srebf1c (Mm00550338_m1), and housekeeping
gene GAPDH (Cat: 4352339E) as endogenous control to correct the variation of RNA and cDNA
loading. Data were analyzed using the ΔCT method. Target gene expression was normalized to
GAPDH for ΔCT value, then calibrated to the control sample in each experiment to give the ΔΔC T
value. Data were calculated based on three replicates in the same experiment and presented as
the means of relative quantification. Error bars represented the Lower and Upper 95%
Confidence Interval. Each set within the experiment was run in triplicate, and each experiment
was performed with an additional run to confirm the repeatability.
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Table 2.2 Primer/probe information for Real-Time RT-qPCR.
Gene

Assay ID

Transcripts

C/EBPβ

Mm00843434_s1

1 RefSeqs

C/EBPα

Mm00514283_s1

1 RefSeqs

PPARγ
Fabp4/aP2
Irs2
Srebf1

Mm01184322_m1
Mm00445878_m1
Mm03038438_m1
Mm00550338_m1

Camp

Mm00438285_m1

2 RefSeqs
1 RefSeqs
1 RefSeqs
1 RefSeqs
1 RefSeqs

Assay design note
primers and probes map within a single
exon (will detect genomic DNA)
primers and probes map within a single
exon (will detect genomic DNA)
probe spans an exon junction
probe spans an exon junction
probe spans an exon junction
probe spans an exon junction
probe spans an exon junction

2.3.7 Statistical analysis
Statistical analyses among multi-group data were carried out using ANOVA followed by
Post Hoc Tukey’s difference test. P < 0.05 was considered significant. Each experiment was
repeated at least twice, and each set within the experiments were run in triplicates.

2.4

Results

2.4.1 Effect of 2-NAP on cell viability
Regardless of insulin, of all the different concentrations of 2-NAP tested in the
experiments described above, none showed effects on cell proliferation as compared to the
positive control (Fig.2.2 A-C). In the presence of insulin, even though the average proliferation
percentages of 2-NAP treated cells in Experiment Insulin+2-NAP D0-8 were slightly higher than
those in Experiment Insulin+2-NAP D3-8, the longer exposure of 2-NAP did not show significant
additional promotion of cell proliferation (Fig.2.2 C).
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2.4.2 Effect of 2-NAP on cell morphology and lipid accumulation
The first hallmark of adipogenesis is the change in cell shape from fibroblast
preadipocytes into spherical, large and lipid producing adipocytes. Figure 2.3 A shows the
morphology change and lipid production in three controls. After staining with Oil Red O, the
positive control and IBMX+DEX control cells increased their size and accumulated cytosolic
triglycerides, indicating the presence of mature adipocytes (Fig.2.3 A lower panel). Stained lipid
droplets as well as spherical cell shapes were observed in all doses of 2-NAP treated cells in both
microscopic pictures and plate pictures, indicating successful cell differentiation (Fig.2.3 B-D).
To quantify lipid accumulation, we developed the whole well scan method by using an
EnSpire multilabel plate reader (PerkinElmer), which detected Oil Red O staining absorbance for
80 spots in each culture well. In the absence of insulin, although the absorbance of all 2-NAP
treated cells in experiment 2-NAP D0-8 was lower than that of the positive control, it was
significantly higher than that of the negative control (P<0.01), indicating the presence of lipidproducing mature adipocytes (Fig.2.4 A).
In the Experiment Insulin+2-NAP D3-8, a higher absorbance in 2-NAP treated cell was
observed compared with the positive control. In particular, cells treated with 100 nM, 1 μM and
10 μM of 2-NAP showed a significantly higher content of lipid droplets, and this difference was
statistically significant (P<0.01) (Fig.2.4 A). Compared to Experiment Insulin+2-NAP D3-8, longer
exposure of 2-NAP at the onset of stimulation (Experiment Insulin+2-NAP D0-8) did not further
upregulate the lipid accumulation as expected, but showed a lesser extent of upregulation
(Fig.2.4 B).
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Figure 2.2 Effects of 2-NAP on 3T3-L1 cell viability.
Cell viability was determined using the XTT assay on the termination day of each experiment. Postconfluent 3T3-L1 cells were induced to differentiation as designed. On the termination day (day 8), culture
medium was carefully removed and replaced with phenol red-free RPMI-1640 containing XTT solution for
4 hour. The absorbance was measured at 450 nm and 690 nm. The results were presented as proliferation
percentage of the negative control and expressed as means ± standard error of triplicate samples.
Statistical analyses among multi-group data were carried out using ANOVA followed by Post Hoc test.
P<0.05 was considered significant. (Neg: negative control; Pos: positive control; IBMX+DEX: IBMX+DEX
control)
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Figure 2.3 continued
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C. Experiment Insulin+2-NAP D3-8

B. Experiment 2-NAP D0-8
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Figure 2.3 continued

40
Plate view
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D. Experiment Insulin+2-NAP D0-8

Figure 2.3 Cell morphology change and lipid accumulation in 2-NAP treated 3T3-L1 cells.
At the termination day, cells were fixed with 10% formalin solution at 4 °C overnight, then stained with
Oil Red-O solution. 2 μM of Rosiglitazone, a known inducer of 3T3-L1 adipogenesis, was used to test
feasibility of the system. Triglyceride droplets stained with Oil Red O were photographed under
microscope at 10X and 20X magnification (microscopic view) or directly (plate view). A. Experimental
controls; B. Experiment 2-NAP D0-8; C. Experiment Insulin+2-NAP D3-8; D. Experiment Insulin+2-NAP D08. (Neg: negative control; Pos: positive control; IBMX+DEX: IBMX+DEX control)
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Figure 2.4 Quantification of lipid accumulation in 2-NAP treated 3T3-L1 cells.
Cytosolic triglyceride droplets stained with Oil Red O were measured by an EnSpire multilabel plate reader
(PerkinElmer) using well area scan mode for the absorbance at 490 nm. The absorbance was expressed as
means ± standard error. Statistical analyses among multi-group data were carried out using ANOVA
followed by Post Hoc test. * donates as P<0.05, ** donates as P<0.01. (Neg: negative control; Pos: positive
control; IBMX+DEX: IBMX+DEX control)
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2.4.3 Effect of 2-NAP on adipogenic gene expression
Adipogenesis is a multi-step process. During terminal adipocytes differentiation, a series
of transcriptional regulators are either activated or suppressed. The first two transcriptional
factors that are stimulated by the differentiation cocktail in vitro are CCAAT-enhancer-binding
protein β and δ (C/EBPβ, C/EBPδ) (Ramji and Foka 2002). Both C/EBPβ and C/EBPδ can induce
the expression of CCAAT-enhancer-binding protein-α (C/EBPα) and peroxisome proliferatoractivated receptor-γ (PPARγ), the two key transcriptional regulators of adipocyte differentiation
(Tang et al. 2005). C/EBPα and PPARγ can directly initiate expression of many adipogenic genes,
including leptin, adipsin, and fatty acid binding protein 4 (FABP4, also as aP2). Therefore, C/EBPα
and PPARγ are commonly used as markers of adipocyte differentiation.
To evaluate terminal adipocyte differentiation on day 8, we focused on the expression of
the two master transcriptional regulators in terminal adipocyte differentiation, C/EBPα and
PPARγ, and one of the adipogenic marker genes, aP2. As illustrated in Figure 2.5, in experiment
2-NAP D0-8, even in the absence of insulin, 1 nM, 1 μM and 10 μM of 2-NAP were able to activate
C/EBPα expression (P<0.05, Fig.2.5 A). In particular, more than two fold increase in upregulation
of C/EBPα expression was seen in cells treated with 10 μM of 2-NAP, compared with the positive
control. 2-NAP was also able to induce PPARγ expression (Fig.2.5 B). Compared to the negative
control, the upregulation of PPARγ expression in 100 pM, 100 nM to 10 μM 2-NAP treated cells
was significantly higher (P<0.05). In particular, 3T3-L1 cells exposed to 10 μM of 2-NAP showed
higher expression of PPARγ than the positive control, suggesting that the induction of PPARγ by
10 μM of 2-NAP was comparable to that of insulin in the standard differentiation protocol. The
expression of aP2 in the 2-NAP D0-8 experiment, though lower than the positive control, was
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significantly elevated by all doses of 2-NAP (P<0.05, Fig.2.5 C), indicating the maturation of
adipocytes.
In the presence of insulin, the addition of 2-NAP from day 3 to day 8 (Experiment
Insulin+2-NAP D3-8) showed an additive effect on terminal adipocyte differentiation. Higher
concentrations of 2- NAP (1 μM and 10 μM) strongly stimulated the expression of C/EBPα
(P<0.01, Fig.2.6 (I) A). The mRNA level of PPARγ in 2-NAP treated cells increased in a dosedependent manner, and was significantly higher than the positive control even at 100 pM
(P≤0.01, Fig.2.6 (I) B). In cells treated with 10 μM of 2-NAP, PPARγ expression was three and two
fold higher than the negative control and positive control, respectively. Expression of the mature
adipocyte-specific gene aP2 was also upregulated by 2- NAP in a dose-dependent manner,
however, only higher concentrations (from 10 nM to 10 μM) of 2-NAP were significantly higher
than the positive control (P<0.05, Fig.2.6 (I)C).
Figure 2.6 (II) shows the comparison of the expression levels of the three marker genes in
Experiment Insulin+2-NAP D0-8 and D3-8. Similar to gene expression levels in Experiment
Insulin+2-NAP D3-8, in Experiment Insulin+2-NAP D0-8 2-NAP upregulated C/EBPα and PPARγ
expression in a dose-dependent manner, and significantly elevated the aP2 level (P<0.01, Fig.2.6
(II)A-B). In contrast, exposure of cells to 2-NAP from the differentiation onset (day 0 to day 8) did
not show higher extent of upregulation on C/EBPα and PPARγ. 2-NAP at 100 nM in Experiment
Insulin+2-NAP D0-8 showed lower C/EBPα and PPARγ expression compared with cells treated
with the same concentration of 2-NAP in Experiment Insulin+2-NAP D3-8 (P<0.01). Even though
cells exposed to 1 nM 2-NAP from day 0 to day 8 showed higher expression of aP2, the other
higher concentrations showed no significant additional effect (Fig.2.6 (II) C). Therefore, in the
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following experiments, we only focused on Experiment Insulin+2-NAP D3-8 to explore the role of
2-NAP during adipogenesis in the presence of insulin.
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Figure 2.5 Effects of 2-naphthol (Experiment 2-NAP D0-8) on adipogenic gene expression at day 8 of 3T3-L1 differentiation.
Major transcriptional regulators in terminal adipocyte differentiation: C/EBPα (A) and PPARγ (B); mature adipocyte-specific protein: aP2 (C). Postconfluent 3T3-L1 cells were induced to differentiate into adipocytes with 0.5 mM IBMX, 0.25 µM DEX and 2-NAP for three days followed by
incubation with 2-NAP alone for six days. Cells treated with the same concentration of IBMX and DEX, and 1 µg/mL insulin for 3 days followed by
1 µg/mL insulin were used as the positive control (Pos), whereas cells maintained with DMEM medium were used as the negative control (Neg).
Gene expression was evaluated by qRT-PCR, normalized to GAPDH expression and expressed as the relative fold change to the negative control.
Data were calculated based on three replicates in the same experiment and presented as the means of relative quantification. Error bars
represented the Lower and Upper 95%CI. Each set within the experiment was run in triplicate, and each experiment was performed with an
additional run to confirm the repeatability. Statistical analyses among multi-group data were carried out using ANOVA followed by Tukey’s
difference test. * denotes p<0.05; ** denotes p=0.01.
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Figure 2.6 Effects of 2-naphthol in the presence of insulin (Insulin+2-NAP) on adipogenic gene expression at day 8 of 3T3-L1 differentiation.
Major transcriptional regulators in terminal adipocyte differentiation: C/EBPα (A) and PPARγ (B); mature adipocyte-specific protein: aP2 (C). Postconfluent 3T3-L1 cells were induced by the standard differentiation protocol, and 2-NAP was exposed to the cells either from day 0 (Experiment
Insulin+2-NAP D0-8) (II) or day 3 (Experiment Insulin+2-NAP D3-8) (I) to day 8. Cells treated with the standard differentiation protocol were used
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as the positive control (Pos), whereas cells maintained with the basic DMEM medium were used as the negative control (Neg). Gene expression
was evaluated by qRT-PCR, normalized to GAPDH expression and expressed as the relative fold change to the negative control. Data were
calculated based on three replicates in the same experiment and presented as the means of relative quantification. Error bars represented the
Lower and Upper 95%CI. Each set within the experiment was run in triplicate, and each experiment was performed with an additional run to
confirm the repeatability. Statistical analyses among multi-group data were carried out using ANOVA followed by Tukey’s difference test. *
denotes p<0.05; ** denotes p=0.01 and *** denotes p<0.01.
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2.4.4 Effect of 2-NAP on signaling and transcriptional cascade of adipogenesis
Based on previous results, we concluded that 2-NAP accelerates adipocyte differentiation
in 3T3-L1 cells at the terminal differentiation phase. To further explore the effect of 2-NAP during
adipogenesis, we aimed to investigate the signaling and transcriptional cascade of adipogenesis
at day 2 and day 5 post induction of differentiation, as well as on the termination day (day 8) in
Experiment 2-NAP D0-8 and Experiment Insulin+2-NAP D3-8. The relative expressions of the
early adipogenesis regulator, C/EBPβ, IRS2 and SREBP1c, which are involved in insulin signaling
pathway during adipogenesis, were evaluated, in addition to C/EBPα, PPARγ and aP2 expression
at day 5 and day 8.
Within the first three days, only cells in Experiment 2-NAP D0-8 were exposed to 2-NAP,
whereas cells in Experiment Insulin+2-NAP D3-8 were exposed to the same differentiation
medium as in the positive control. On day 2, in the absence of insulin, 2-NAP treated cells
(Experiment 2-NAP D0-8) activated IRS2 and SREBP1c gene expressions (Fig.2.7 A-B). IRS2 mRNA
levels were comparable to that induced by insulin in the positive control, which was about five
fold of the negative control. SREBP1c mRNA levels were significantly increased in a dosedependent manner with 2-NAP treatment compared with the positive control (P<0.05). Similar
levels of C/EBPβ mRNA expression (Fig.2.7 C) were observed among 2-NAP treated cells and the
positive control, indicating that 2-NAP may contribute to C/EBPβ expression during the initiation
phase of adipogenesis, in a similar fashion as insulin. 100 nM and 10 μM 2-NAP significantly
upregulated the expression of C/EBPα by 60 and 45 fold compared to the negative control, and
three and two fold compared to the positive control, respectively. PPARγ expression was

49

moderately affected by 2-NAP (Fig.2.7 D and E). The expression of aP2 in 2-NAP treated cells was
comparable to the positive control (Fig.2.7 F).
On day 5, in Experiment 2-NAP D0-8 and Experiment Insulin+2-NAP D3-8, levels of both
IRS2 and SREBP1c expression were downregulated to levels comparable to the negative control.
No significant difference was detected between 2-NAP treated cells and the positive control (Fig.
2.8 A and B, blue diamond). Moreover, C/EBPβ expressions were extensively suppressed on day
5 in both 2-NAP treated cells and the positive control, compared to the negative control (Fig.2.8
C). This result is consistent with the C/EBPβ expression pattern observed during adipocyte
differentiation in the 3T3-L1 model, where C/EBPβ is activated immediately after stimulation,
maintained at the maximal expression level for about 48 hours, and then declined to the level of
undifferentiated cells (Tang and Lane 1999). In both experiments, all C/EBPα expressions in the
positive control and 2-NAP treated cells decreased from more than 20 fold to three to five fold
of the negative control, compared with the expression on day 2 (Fig.2.8 D). Cell treated with
insulin and 2-NAP (Experiment Insulin+2-NAP D3-8) showed slightly higher C/EBPα expression
level than cells treated with 2-NAP in the absence of insulin (Experiment 2-NAP D0-8). With the
standard differentiation protocol, the expression of aP2 was activated on day 2, and reached the
maximum on day 5 (Fig.2.7F and 2.8F, positive control). In both experiments, 2-NAP treated cells
showed the same aP2 expression pattern (Fig.2.7F and 2.8F). In the absence of insulin
(Experiment 2-NAP D0-8), 2-NAP was able to activate aP2 expression to a level similar to that of
the positive control on day 2; however, on day 5, the upregulated levels of aP2 in 2-NAP treated
cells were significantly lower than in the positive control. Conversely, in Experiment insulin+2-
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NAP D3-8, the expression level of aP2 in 2-NAP treated cells was comparable to the level
observed in the positive control (Fig.2.7F).
On day 8, in the absence of insulin (Experiment 2-NAP D0-8), 2-NAP was capable of
upregulating aP2 expression to a similar level of the positive control (Fig.2.8 F). In presence of
insulin, (Experiment Insulin+2-NAP D3-8), 2-NAP upregulated the expression levels of C/EBPα,
PPARγ and aP2 (Fig.2.8 D-F) to levels significantly higher than those of the positive control. Taken
together, 2-NAP significantly upregulated C/EBPα and PPARγ expression during the entire
terminal differentiation phase, and finally increased the expression of aP2 in the presence or
absence of insulin.

51
B. SREBP1c

A. IRS2
**

**
**

5
4
3
2
1

**

3.5

mRNA relative fold change

mRNA relative fold change

6

**

3

**

2.5
2
1.5
1
0.5
0

0
Neg

Pos

100 nM

Neg

10 μM

Pos

D. C/EBPα

C. C/EBPβ

70

**

*

2500

*

2000

**

1500
1000
500

mRNA relative fold change

3000

mRNA relative fold change

10 μM

2-NAP D0-8

2-NAP D0-8

***
**

60
50
40

**

30
20
10

0

0
Neg

Pos

100 nM

10 μM

Neg

Pos

2-NAP D0-8

100 nM
10 μM
2-NAP D0-8

*

3.5

*

3
2.5

*

*

2
1.5
1
0.5
0
Neg

Pos

100 nM

10 μM

2-NAP D0-8

aP2 mRNA relative fold change

F. aP2

E. PPARγ
PPARγ mRNA relative fold change

100 nM

8

**

7
6

**

*

100 nM

10 μM

5
4
3
2
1
0
Neg

Pos

2-NAP D0-8

Figure 2.7 Effects of 2-naphthol on IRS2, SREBP1c, and adipogenic gene expression at day 2 of 3T3-L1
differentiation.
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Downstream adaptor of insulin receptors: IRS2 (A); insulin-regulated lipogenic transcriptional factor:
SREBP1c (B); early transcriptional factor in initiation phase of adipocyte differentiation: C/EBPβ (C); major
transcriptional regulators in terminal adipocyte differentiation: C/EBPα (D) and PPARγ (E); mature
adipocyte-specific protein: aP2 (F). Post-confluent 3T3-L1 cells were induced to differentiate into
adipocytes as designed. Gene expression was evaluated by qRT-PCR, normalized to GAPDH expression
and expressed as the relative fold change to the negative control. Data were calculated based on three
replicates in the same experiment and presented as the means of relative quantification. Error bars
represented the Lower and Upper 95%CI. Each set within the experiment was run in triplicate, and each
experiment was performed with an additional run to confirm the repeatability. Statistical analyses among
multi-group data were carried out using ANOVA followed by Tukey’s difference test. * denotes p<0.05; **
denotes p=0.01 and *** denotes p<0.01.
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Figure 2.8 Effects of 2-naphthol in the presence or absence of insulin on adipogenic gene expression at
day 5 and day 8 of 3T3-L1 differentiation.
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Downstream adaptor of insulin receptor: insulin receptor substrate 2 (IRS2) (A); insulin-regulated
lipogenic transcriptional factor: sterol responsive element binding protein 1c (SREBP1c) (B); early
transcriptional regulator, C/EBPβ (C); major transcriptional regulators in terminal adipocyte
differentiation: C/EBPα (D) and peroxisome proliferator-activated receptor-γ (PPARγ) (E); mature
adipocyte-specific protein: fatty acid binding protein 4 (aP2) (F). Post-confluent 3T3-L1 cells were induced
to differentiate into adipocytes as designed. Gene expression was evaluated by qRT-PCR, normalized to
GAPDH expression and expressed as relative fold change to negative control. Data were calculated based
on 3 replicates in the same experiment and presented as the means of relative quantification. Error bars
represented the Lower and Upper 95%CI. Each set within the experiment was run in triplicate, and each
experiment was performed with an additional run to confirm the repeatability. Statistical analyses among
multi-group data were carried out using ANOVA followed by Tukey’s difference test. * denotes p<0.05.
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2.5

Discussion
PAHs are a large family of environmental chemical pollutants present in the air, and 2-

NAP is one of the biomarkers of PAH exposure in humans. Results from a recent study show that
the concentration of 2-NAP in the urine is positively linked to increased body mass index and
obesity in children (Scinicariello and Buser 2014). Despite such epidemiological association, the
direct relationship between 2-NAP exposure and adipocyte differentiation has not yet been
determined using laboratory models. Mouse 3T3-L1 preadipocytes are a commonly used and a
well-studied in vitro cell model for adipocytes and obesity-related research. The combination of
IBMX, DEX, and insulin for 2-3 days followed by insulin alone has been established as the standard
mean to trigger the differentiation of confluent 3T3-L1 cells (Green and Kehinde 1975; Rubin et
al. 1978). Based on this standard differentiation protocol, 3T3-L1 cells have been widely used in
analyzing the impact of chemicals and the molecular mechanisms of action in adipocytes. A
variety of chemicals has been studied for their roles in regulating adipogenesis via this model,
including hormones like 17β-estradiol (Jeong and Yoon 2011), endocrine disruptors like BPA
(Masuno et al. 2005) and tolylfluanid (Neel et al. 2013), and heavy metals such as cadmium (Lee
et al. 2012). In the present study, we designed two sets of experiments to address the following
questions: i) whether 2-NAP itself can accelerate 3T3-L1 differentiation initiated by the
combination of IBMX and DEX; ii) whether 2-NAP in combination with insulin can further
accelerate 3T3-L1 differentiation. Therefore, according to the time course and the components
of the standard differentiation protocol, we exposed the chemical to the cells either at the onset
of differentiation (day 0) or after the induction (day 3) with or without insulin.
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In this study, we developed an alternative method of quantifying lipid accumulation in
differentiated 3T3-L1 cells within the culture plates, instead of comparing the intensity of
isopropanol-extracted Oil Red O staining from lipid-producing adipocytes. In our experimental
system, lipid-producing 3T3-L1 cells were grown as scattered clusters over the Costar 6-well
culture plates (Fig.2.3). Moreover, this brand of culture plates is reported to have the lowest
differentiation ratio compared to other culture plate brands (Mehra et al. 2007). Because of the
scattered distribution and the low differentiation rate, the amount of Oil Red O staining extracted
from lipid-producing cells will be greatly affected by the dye that remains on the outside of cells
and plastic plates. Therefore, the common method using the dye extraction to quantify lipid
accumulation is not suitable and accurate in our system. The whole well scan method allows us
to divide each culture well into 80 scan spots and precisely quantify the red absorbance on nonhomogenized cell grown surface. In addition, this method also minimizes the variables of the
average absorbance of each well that are created by empty spots where cells are detached from
the plates and washed away during the staining process.
In the first set of experiments (Experiment 2-NAP D0-8), 3T3-L1 differentiation was
initiated by the combination of IBMX and DEX, and insulin in the standard differentiation protocol
was replaced by 2-NAP. After 9 days treatment, regardless of the concentration, 2-NAP-treated
3T3-L1 cells successfully differentiated from fibroblasts into mature adipocytes. In addition, 2NAP increased lipid droplet production in 3T3-L1 cells induced by IBMX and DEX (Fig.2.3 B). The
quantification results confirmed the significance of 2-NAP-induced upregulation of lipid
accumulation (Fig.2.4 A). Compared to the positive control, 2-NAP even at the highest
concentration did not induce a comparable amount of lipid in 3T3-L1 cells. This result is confirmed
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by aP2 expression at mRNA level. aP2 is specifically expressed in mature adipocytes and functions
as a mediator of lipid transportation and metabolization (Gorbenko et al. 2006). On day 5 and
day 8 aP2 was markedly less expressed in 2-NAP-treated cells than the positive control (Fig.2.5 C
and Fig.2.8 F). These results demonstrate that, in comparison to insulin, 2-NAP exerts a reduced
effect on lipid accumulation in adipocytes. The expression of transcriptional regulators of
adipogenesis and key molecules involved in insulin pathway was another important marker to
evaluate. In this study, the two master transcriptional regulators of adipogenesis C/EBPα and
PPARγ were elevated in a dose-dependent manner by 2-NAP during adipogenesis. Particularly,
2-NAP at higher concentrations significantly increased expression of C/EBPα and PPARγ levels at
their 48-hour peak time as well as during the terminal differentiation phase (Fig.2.5 A-B and
Fig.2.7 D-E). Compared to the positive control, similar expression levels of C/EBPβ and IRS2, as
well as upregulated expression of SREBP1c induced by 2-NAP in the combination of IBMX and
DEX, suggested that 2-NAP is able to elevate early factors in the signal cascade of adipogenesis
despite the absence of insulin.
In the second set of experiments (Experiment Insulin+2-NAP D3-8), 3T3-L1 differentiation
was induced by the standard differentiation protocol, and 2-NAP treatment was started on day
3 in order to evaluate its effect on the terminal differentiation phase. As expected, 2-NAP
increased lipid accumulation in 3T3-L1 cells induced by the standard differentiation protocol
(Fig.2.4 A), and elevated gene expression levels of C/EBPα and PPARγ in a dose-dependent
manner (Fig.2.6 I). In particular, as low as 100 pM of 2-NAP was capable of upregulating PPARγ
expression on the termination day. On the other hand, in Experiment Insulin+2-NAP D0-8, where
2-NAP was added on day 0 together with IBMX, DEX and insulin, both lipid accumulation and
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marker gene expression results did not show any additive effect on termination day, indicating
that 2-NAP in the presence of insulin exerts its modulating role on adipogenesis during the
terminal differentiation phase (Fig.2.4 B and Fig.2.6 II).
Many epidemiological and laboratorial studies in vitro and in vivo have identified
intriguing links between environmental endocrine disrupting chemicals (EDC) and obesity. A
variety of EDCs have been screened for their hormone receptor-binding affinity and adipogenic
potential. Structurally similar to endogenous hormones, 2-NAP has the ability to bind estrogen
receptors (Schultz and Sinks 2002) and thyroid hormone receptors (Sun et al. 2008). Thus, 2-NAP
is characterized as a potential EDCs. This study is the first to report the adipogenic property of 2NAP. Here, we show that, regardless of insulin, 2-NAP at higher concentrations promotes the
expression of C/EBPα and PPARγ during terminal differentiation. In addition, 2-NAP is capable of
activating and upregulating expression of IRS2 and SREBP1c, the two molecules involved in and
regulated by the insulin signaling pathway (Fig.2.7 A-B and Fig.2.8 A-B). This finding suggests that
2-NAP may induce 3T3-L1 differentiation via the PPARγ pathway and may modulate the action of
insulin pathway during adipogenesis. Of course, the possibility of using other pathways and
multiple pathways at one time cannot be excluded. Further work will be needed to fully elucidate
the utilization of signaling pathways under variant conditions.
In conclusion, 2-NAP is capable of inducing adipocyte differentiation of 3T3-L1 cells by
regulating molecules involved in the insulin signaling pathway, and transcriptional regulators of
adipogenesis. Therefore, 2-NAP plays a potential role in interrupting lipid homeostasis, possibly
leading to obesity and associated disorders.
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3

3.1

Chapter 3: The effect of lead on 3T3-L1 adipocyte differentiation is non-monotonic

Summary
Currently available data on the association between lead exposure and obesity are

inconclusive. A recent epidemiological study shows that a blood lead concentration higher than
1.10 μg/dL is associated with a lower body mass index and obesity in both children and
adolescents. Moreover, another study indicates that mice exposed to 109 ppm of lead via
drinking water exhibit decreased body weight when compared to their counterparts subjected
to lower levels of lead exposure, but are significantly bigger than the controls. Therefore, we
hypothesized that lead at lower concentrations induces adipogenesis, whereas at higher
concentrations lead suppress this induction effect.
3T3-L1 cells were induced by the standard differentiation cocktail containing IBMX, DEX,
and insulin for the first three days (day 0-2), followed by DMEM medium containing only insulin
for six days (day 3-8). Three one-hundred-fold concentrations of lead (1 nM to 10 μM) were
exposed to the cells in three experimental protocols. In the first experimental protocol
(Insulin+Pb D3-8), cells were induced by the standard differentiation medium with IBMX, DEX,
and insulin for three days, followed by insulin and lead for six days. In the second experimental
protocol (Insulin+Pb D0-8), cells were induced by IBMX, DEX, and insulin together with lead for
three days, followed by insulin and lead for six days. In the third experimental protocol (Pb D08), cells were induced by IBMX, DEX, and lead for three days, followed by lead alone for six days.
The terminal differentiation was evaluated by cell morphology and lipid production. The
transcriptional cascade of adipogenesis was assessed by quantifying the expression of the early
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transcriptional factor C/EBPβ, two major transcriptional regulators of terminal adipocyte
differentiation C/EBPα and PPARγ, and the mature adipocyte-specific gene aP2.
Results from all three experiments show that all lead-treated cells differentiated from
fibroblast cells into mature lipid-producing spherical adipocytes, indicating the induction of
adipogenesis. Lead at 10 μM, however, showed the least induction on lipid accumulation when
compared with lower concentrations. Analysis of the transcriptional cascade of adipogenesis
revealed that in the presence of insulin, in the Insulin+Pb D0-8 experiment, lead increased the
expression of C/EBPβ, C/EBPα, PPARγ, and aP2 after 48 hours during the early differentiation
phase. In both Insulin+Pb experiments, C/EBPα remained upregulated on day 5 and day 8 in lead
treated cells. Moreover, 10 μM of lead significantly suppressed the expression of PPARγ and aP2
from day 5 to day 8 in both Insulin+Pb experiments. On the other hand, in the absence of insulin
(experiment Pb D0-8), the upregulation of C/EBPα, PPARγ, and aP2 was observed from day 5 in
lead-treated cells. In 10 μM lead treated cells, aP2 was significantly upregulated after 48 hours,
and the expression of C/EBPα, PPARγ, and aP2 was significantly higher than that in cells treated
with lower concentrations of lead. On day 8, however, gene expression induced by 10 μM of lead
drastically declined.
In conclusion, lead induces adipocyte differentiation by modulating the C/EBPα pathway.
Lead promotes adipogenesis by upregulating C/EBPα and aP2 expressions during the early phase;
however, during the terminal differentiation phase, a high concentration of lead attenuates the
induction of adipogenesis by suppressing PPARγ and aP2 expression. Therefore, although lead
plays a potential role in inducing obesity, higher concentrations of lead may result in minimal
obesity-related effects.
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3.2

Introduction
Results from studies on the association between lead exposure and obesity are

inconclusive. A recent epidemiological study, using multiple logistic and multivariate linear
regression to analyze the blood lead level with the body mass index (BMI) from NHANES 19992006, shows that higher lead concentration in blood is associated with lower BMI and obesity
among all the participants, including children and adolescents (Scinicariello et al. 2013). A
longitudinal study conducted with Boston children reported a statistically significant increased
association with BMI and dentin lead level, but no association with bone lead level (Kim et al.
1995). Several cross-sectional studies with children and adults found no association between BMI
and blood lead level, while other studies reported an inverse dose-response relationship among
specific populations, including children and adult women. The Donald group using the mouse
model and the Hamir group using the dog model found out that lead exposure is associated with
lower body weight (Donald et al. 1988; Hamir et al. 1981), whereas in Leasure’s mouse study,
mice exposed to higher levels of lead exhibited decreased body weight when compared to lower
lead exposure counterparts, but significantly increased than the controls (Leasure et al. 2008).
Therefore, the effect of lead exposure on obesity needs to be clarified.
In this study, we aimed to investigate the effect of lead on adipocyte differentiation and
lipid homeostasis in vitro to test our hypothesis that lower concentrations of lead upregulate
adipogenesis, but higher concentrations do not. Mouse 3T3-L1 cells were initiated with the
differentiation cocktail, then incubated with three one-hundred-fold concentrations of lead (1
nM, 100 nM, 10 μM). Terminal adipocyte differentiation was evaluated by lipid accumulation,
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gene expression of transcriptional regulators and mature adipocyte markers, as well as molecules
involved in the insulin signaling pathway.

3.3

Materials and methods

3.3.1 Materials
Mouse embryo fibroblast 3T3-L1 cells (ATCC CL-173, lot 59796011) and bovine calf serum
(ATCC, 30-2030) were obtained from ATCC. Dulbecco’s modified Eagle’s medium (DMEM)
(Cellgro 10-013CV) and 100X penicillin- streptomycin solution (Cellgro 30-002-CI) were purchased
from Mediatech, Inc. Human insulin solution (I9278), dexamethasone (D2915), 3-Isobutyl-1methylxanthine (I5879), formalin solution (HT501128), and Oil Red O (O0625) were obtained
from Sigma-Aldrich Co. LLC. Lead acetate solution (SL9000-250) was purchased from Fisher
Scientific Co. In this study, lead acetate was used as the source for all lead exposure experiments.
3.3.2 Experimental design
To test whether lead influences adipogenesis, we exposed 3T3-L1 preadipocytes to lead
by three different protocols (Fig.3.1). Cells treated with the standard differentiation protocol
were used as the positive control, whereas cells maintained with the basic DMEM medium were
used as the negative control. In the first experiment (Insulin+Pb D3-8), lead was added to cell
cultures on day 3, in order to evaluate its effect on the terminal differentiation phase of
adipogenesis. In the second experiment (Insulin+Pb D0-8), lead was exposed to the cells at the
onset of differentiation (on day 0). In the third experiment (Pb D0-8), lead substituted insulin in
the standard protocol and was kept in the culture medium from day 0 to day 8. Cell viability, cell
morphology change, and lipid production were investigated; and the expression of marker genes
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of adipogenesis, C/EBPα, PPARγ, and aP2 was evaluated on termination day. To assess the
transcriptional cascade during early and terminal differentiation phases, the expression of
C/EBPβ, IRS2, and SREBP1c was quantified at different time points during adipogenesis.
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A. Positive control protocol

C. Lead exposure protocols
1) Experiment Insulin+Pb D3-8

B. IBMX+DEX control protocol

2) Experiment Insulin+Pb D0-8

3) Experiment Pb D0-8

Figure 3.1 Protocols for adipogenic differentiation and lead exposure in 3T3-L1 cells.
Cells were differentiated one day after confluence (designated as day 0, indicated by the first black arrow)
by replacing the DMEM medium with the differentiation medium for 3 days. The concentrations of each
component in the differentiation medium were 0.5 mM for IBMX, 0.25 μM for dexamethasone (DEX) and
1 μg/mL for insulin. On Day 3 (indicated by the second black arrow), the differentiation media were
changed to DMEM medium with 1 μg/mL insulin. Three one-hundred-fold concentrations of lead (1 nM
to 10 μM) were exposed to the cells in three experimental protocols. Experiment 1: Insulin+Pb D3-8, cells
were induced by the standard differentiation medium with IBMX, DEX, and insulin for three days followed
by insulin and lead for six days. Experiment 2: Insulin+Pb D0-8, cells were induced by IBMX, DEX, and
insulin together with lead for three days followed by insulin and lead for six days. Experiment 3: Pb D0-8,
cells were induced by IBMX, DEX, and lead for three days followed by lead alone for six days. The lead
exposure period in each experiment is indicated by the blue curly bracket.
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3.3.3 Cell culture and differentiation
3T3-L1 cells were cultured in the DMEM medium supplied with 10% bovine calf serum
(BCS), 100 I.U. penicillin and 100 μg/mL streptomycin. Cells were grown in 75 cm2 culture flask
in a humidified atmosphere with 5% CO2 at 37 °C, and subcultured when they became 80%
confluent.
Cells were seeded at a density of 6x104 cells/well in Costar 6-well plates with the basic
DMEM medium. In the cell viability test, cells were seeded at 5000 cells/well in 96-well plates.
48 hours later (Day 0), cell differentiation was induced by replacing the basic DMEM medium
with differentiation media for three days (day 0 to day 2), followed by the chemical-containing
medium for six days. The concentrations of each component in the standard differentiation
cocktail were 0.5 mM for IBMX, 0.25 μM for DEX, and 1 μg/mL for insulin. Differentiation media
containing IBMX and DEX with or without insulin were used for the positive control and the
IBMX+DEX control, respectively. In lead experiments, the differentiation medium containing
IBMX, DEX, and lead was used for Experiment Pb D0-8 differentiation, whereas the differentiation
medium containing IBMX, DEX, and insulin with or without lead was used for the Insulin+Pb
experiments. On Day 3, differentiation media were changed to DMEM medium with 1 μg/mL
insulin for the positive control; the basic DMEM medium for the IBMX+DEX control; DMEM
medium with lead for Experiment Pb D0-8; or DMEM medium with 1 μg/mL insulin and lead for
Insulin+Pb experiments, respectively, until the end of experiments (day 3 to day 8). Three onehundred-fold concentrations of lead, 1 nM, 100 nM, and 10 μM, were used in these experiments.
3T3-L1 cells maintained with the basic DMEM medium were used as the negative control.
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3.3.4 Oil Red O staining
On the termination day, adipocytes were stained with Oil Red O solution. Briefly, the
culture medium was gently and slowly removed from each well, and cells were washed twice
with 1X phosphate buffered saline (PBS). Cells were then fixed with 10% formalin solution at 4
°C overnight or longer. After formalin fixation, cells were washed with DI water twice and
incubated with 1.5 mL 60% isopropanol for 5 min at room temperature. After removal of
isopropanol, cells were dried completely at room temperature, then incubate with 1 mL Oil Red
O working solution for 30 min. Subsequently, cells were washed with DI water for three times,
dried and analyzed under the microscope. The Oil Red O working solution is stable for only 2
hours, so it was prepared freshly before use. Oil Red O stock was made by dissolving 300 mg Oil
Red O powder in 100 mL isopropanol (this stock is stable for one year). The working solution
was prepared as follow: Oil Red O stock was filtered by Whatman filter papers and diluted with
DI water at a 3:2 ratio. After 10 min incubation, the Oil Red O working solution was filtered with
a 0.22 μm syringe filter.
Triglyceride droplets stained with Oil Red O were quantified by measuring the absorbance
at 490 nm using an EnSpire multilabel plate reader (PerkinElmer) with well area scan mode
(Program setting parameters in Table 2.2). The absorbance was expressed as means ± standard
error of 80 spots scanned for each sample.
3.3.5 XTT assays
Cell viability was tested on the termination day of experiments by XTT assays. The XTT
assay measures the mitochondrial dehydrogenase activity in viable cells. The tetrazolium ring of
XTT salt can be reduced by mitochondrial dehydrogenase of living cells, resulting in a water-
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soluble orange formazan derivative. In brief, cells were seeded in 96-well plates and cultured
according to the experimental protocol mentioned above. On termination day, the culture
medium was replaced by 100 μL freshly prepared XTT working solution. After 4-hour incubation
at 37 °C, the absorbance of orange formazan was measured at 450 nm and 690 nm with a BioTek microplate spectrophotometer. The results were presented as proliferation percentage of
the negative control and expressed as means ± standard error of triplicate samples.
3.3.6 Quantitative real-time reverse transcription-polymerase chain reaction (Real-Time
PCR)
Total RNA was extracted from cells using the QIAGEN RNeasy Plus Mini Kit (Qiagen Inc.,
Valencia, CA). 5 μL, 7.5 μL and 10 μL of total RNA extracted on Day 8, Day 5, and Day 2 respectively
was reverse transcribed into cDNA using a High-Capacity cDNA reverse transcription kit (Applied
Biosystems). The reaction mixture contained 1x reverse transcriptase buffer, 4 mM dNTP
(deoxynucleotide triphosphate), 5x Random primers, 1 U RNase inhibitors, and 2.5 U of
MultiScribe Reverse Transcriptase. The RT-PCR was performed with the following cycle
parameters: 25°C for 10 min, 37°C for 120 min, and 85°C for 5 min. Synthesized cDNA was diluted
with RNase-free water. Then, quantitative real-time PCR amplification was performed with
appropriate sets of primers using Taqman gene expression assays in a total volume of 20 μL
containing aliquot cDNA samples. The gene expression assays were carried out with the following
cycle parameters: 55°C for 2min; 94°C for 10 min; 40 cycles of 94°C for 15 sec and 60°C for 60
sec. The primers and probes were obtained from Applied Biosystems: C/EBPα
(Mm00514283_s1),

C/EBPβ

(Mm00445878_m1),

Irs2

(Mm00843434_s1),

(Mm03038438_m1),

PPARγ

Srebf1c

(Mm01184322_m1),

(Mm00550338_m1),

and

aP2
the
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housekeeping gene GAPDH (Cat: 4352339E) as endogenous control to correct the variation of
RNA and cDNA loading. Data were analyzed using the ΔCT method. Target gene expression was
normalized to GAPDH for ΔCT value, then calibrated to the control sample in each experiment to
give the ΔΔCT value. Data were calculated based on three replicates in the same experiment and
presented as the means of relative quantification. Error bars represented the Lower and Upper
95% Confidence Interval. Each set within the experiment was run in triplicate, and each
experiment was performed with an additional run to confirm the repeatability.
3.3.7 Statistical analysis
Statistical analyzes among multi-group data were carried out using ANOVA followed by
Tukey’s difference test. P < 0.05 was considered significant. Each experiment was repeated at
least twice, and each set within the experiments were run in triplicates.

3.4

Results

3.4.1 The induction of lead on lipid accumulation
When cells were exposed to lead in presence of insulin during the 9-day differentiation,
lipid production was upregulated in cells treated with lead from day 3 to day 8 (Experiment
Insulin+Pb D3-8), but a lesser extent of upregulation was observed in cells treated with the
highest concentration of lead at 10 μM (Fig.3.2, top left plate). Quantification of lipid
accumulation by whole well scan at 490 nm further proved that the absorbance averages from
cells treated with all concentrations of lead were significantly higher than the one from the
positive control (Fig.3.3, P<0.01). In comparing the dose effects of lead treatment on lipid
production, the results revealed that cells treated with 10 μM of lead showed significantly lower
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induction on lipid production (1.25 fold of the positive control) than that with 1 nM of lead (1.5
fold and 1.4 fold, respectively) (P≤0.01); whereas no difference was observed between 1 nM and
100 nM, and 100 nM and 10 μM of lead treated cells.
Similar results of increased lipid production were observed in Experiment Insulin+Pb D08. The highest concentration of lead at 10 μM showed an apparent decrease of induced lipid
production, compared to the lower concentrations of lead which drastically upregulated lipid
accumulation (Fig.3.2, top right plate). Quantification of lipid production demonstrated that
there is no significant difference between the cells treated with 10 μM of lead and the positive
control, whereas 1 nM and 100 nM of lead increased lipid production to 1.5 fold of the positive
control (Fig.3.3, P<0.01). Compared to Experiment Insulin+Pb D3-8, early exposure from the
onset of adipocyte differentiation (day 0) did not show additional effects on lipid homeostasis.
In the absence of insulin, cells (IBMX+DEX control) exhibited less adipogenesis with fewer
and smaller mature adipocytes (Fig.2.2 A) and lesser lipid accumulation when compared to the
positive control (Fig.2.3, and Fig.3.2, bottom left plate middle wells). In Experiment Pb D0-8,
when insulin was absent from the cell culture, lead was still capable of increasing lipid production
up to a level similar to that of the positive control. Results from quantification of lipid
accumulation confirmed that no difference in absorbance existed between lead-treated cells and
the positive control (Fig.3.3). Even when cells treated with 10 μM of lead exhibited fewer lipid
droplets than cells treated with 1 nM and 100 nM of lead, the difference was still not significant.
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Figure 3.2 Effects of lead on cell morphology change and lipid accumulation.
At termination day, cells were fixed with 10% formalin solution at 4 °C overnight and then stained with
Oil Red-O solution. Triglyceride droplets stained with Oil Red-O were photographed. (Upper left plate:
Experiment Insulin+Pb D3-8; Upper right plate: Experiment Insulin+Pb D0-8; Bottom left plate: negative,
IBMX+DEX, and positive control; Bottom right plate: Experiment Pb D0-8)
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Figure 3.3 Quantification of lipid accumulation in lead treated 3T3-L1 cells.
Cytosolic triglyceride droplets stained with Oil Red-O were measured by an EnSpire multilabel plate reader
(PerkinElmer) using the well area scan mode for the absorbance at 490 nm. The absorbance was expressed
as means + SEM. Statistical analyses among multi-group data were carried out using ANOVA followed by
Tukey’s difference test. * denotes p<0.01. (Neg: negative control; Pos: positive control)

72

3.4.2 Negative regulation of lead on cell proliferation
As shown in Figure 3.4, the positive control showed a significantly higher proliferation
rate compared to the negative control (P<0.01). The IBMX+DEX control, where no insulin was
present during the whole experimental period, showed a lower proliferation rate (73%) than the
positive control (P<0.05) but higher than the negative control (40%). This result was consistent
with the finding that insulin promotes cell proliferation via the PI3K pathway (Jung et al. 2000).
In addition, the re-entry into the cell cycles, which is referred to as mitotic clonal expansion, has
been demonstrated to be crucial for initiating adipogenesis (Tang et al. 2003). Moreover, for 3T3L1 preadipocytes, the combination of IBMX and DEX is enough to initiate full adipocyte
differentiation in 96 hours (Pantoja et al. 2008). Taken together, these findings indicate that, in
the IBMX+DEX+insulin differentiation cocktail, insulin may play a role in accelerating cell
proliferation during mitotic clonal expansion and the differentiation process of 3T3-L1
preadipocytes.
In the presence of insulin, in Experiment Insulin+Pb D3-8, only lead at the highest
concentration of 10 μM showed a suppressive role on cell proliferation (62%), compared with
the positive control (P<0.01) (Fig.3.4). In Experiment Insulin+Pb D0-8, similar to Experiment D38, only lead at 10 μM showed a significantly suppressive role on cell proliferation (82%) (P<0.05).
Regardless of the exposure length, lead at the two lower concentrations showed no different
influence on cell growth, whereas a decreasing trend of cell proliferation was observed at 10 μM
in both Experiment Insulin+Pb D3-8 and D0-8.
In Experiment Pb D0-8, because of the absence of insulin, all lead -treated cells exhibited
lower cell proliferation compared to the positive control (P<0.01). However, when compared to
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the IBMX+DEX control, only lead at 10 μM suppressed cell proliferation (P<0.01). Regardless of
insulin presence, when comparing Experiment Pb D0-8 with Experiment Insulin+Pb D0-8, the
same response pattern was observed: lower concentrations of lead had no effect, but the higher
concentration had a suppressive effect on cell proliferation.
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Figure 3.4 Effects of lead on 3T3-L1 cell viability.
Cell viability was determined using the XTT assay on termination day (day 8) of each experiment. Postconfluent 3T3-L1 cells were induced to differentiation as designed. On termination day, culture medium
was carefully removed and replaced with phenol red-free RPMI-1640 containing XTT solution for 4 hour.
The absorbance was measured at 450 nm and 690 nm. The results were presented as proliferation
percentage of the positive control and expressed as means + SEM of triplicate samples. Statistical analyses
among multi-group data were carried out using ANOVA followed by Tukey’s difference test. * denotes as
P<0.05; ** denotes as P<0.01. (Neg: negative control; Pos: positive control; IBMX+DEX: IBMX+DEX control)
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3.4.3 Effect of lead on adipogenic genes
To study the effect of lead on adipogenesis at the gene level, we quantified the expression
of three marker genes of terminal adipocyte differentiation at the end of the experiments (day
8). In the presence of insulin, when lead was exposed to the cells from day 3 to day 8 (Experiment
Insulin+Pb D3-8) lead treated cells showed higher expression of the transcriptional regulator
C/EBPα on day 8 than the positive control; however, this difference was not significant. The more
important regulator PPARγ was slightly suppressed by 10 μM of lead. The mature adipocytespecific gene aP2 was significantly upregulated in cells treated with 100 nM of lead (P<0.01), but
was significantly suppressed in cells treated with 10 μM of lead (P<0.05, Fig.3.5 A). Therefore, in
Experiment Insulin+Pb D3-8, 10 μM lead suppressed PPARγ and aP2 expressions on day 8, even
though it was capable of increasing lipid accumulation.
When cells were exposed to lead from day 0 to day 8 in the presence of insulin
(Experiment Insulin+Pb D0-8), C/EBPα and aP2 was increased by 1 nM and 100 nM of lead on day
8 (Fig.3.5 B), but only the upregulation of C/EBPα with 1 nM of lead treatment was significant
(P<0.05). Lead at lower concentrations did not show any effect on PPARγ expression on day 8. In
contrast, all three marker genes were suppressed by 10 μM of lead. In particular, C/EBPα and
PPARγ were significantly downregulated (P<0.05), even below the levels of the negative control.
When comparing the dose-response difference, the expression levels of the three genes were
regulated by lead in an inverse dose-response shape. Significantly decreased gene expression
levels were observed between lower concentrations of lead and 10 μM of lead (P<0.01).
In the absence of insulin, in Experiment Pb D0-8 on day 8, the IBMX+DEX control showed
higher levels of C/EBPα, PPARγ, and aP2 expression than the positive control (Fig.3.5 C, P<0.01).
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Lead at 1 nM significantly upregulated C/EBPα and aP2 expressions, compared to both the
positive control and the IBMX+DEX control (P<0.01). Lead at 100 nM also upregulated the
expressions of C/EBPα and aP2 compared to the IBMX+DEX control, but was only able to
significantly increase C/EBPα expression (P<0.05). Lead at 10 μM showed no significant effect on
C/EBPα, even though the expression was a little higher than the IBMX+DEX control; however,
PPARγ and aP2 were significantly suppressed by 10 μM of lead (P<0.05) when compared to the
IBMX+DEX control. Notably, PPARγ was significantly suppressed by all three concentration of lead
(P<0.01) when compared to the IBMX+DEX control. Compared with Experiment Insulin+Pb D0-8,
a similar dose-response pattern was observed in Experiment Pb D0-8: lead affected terminal
differentiation marker genes in an inverse dose-response pattern.
Taken together, our results show that on termination day, the presence of lead at lower
concentrations upregulated the expression of C/EBPα and aP2, while higher concentration of
lead suppressed the expression of PPARγ and aP2, regardless of insulin presence.
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Figure 3.5 Effects of lead on adipogenic gene expression at day 8 of 3T3-L1 differentiation.
Major transcriptional regulators in terminal adipocyte differentiation: C/EBPα and PPARγ; mature adipocyte-specific protein: aP2 were evaluated
in each experiment: Experiment Insulin+Pb D3-8 (A), Experiment Insulin+Pb D0-8 (B), and Experiment Insulin+2-NAP D3-8 (C). Cells treated with
the standard differentiation protocol were used as the positive control (Pos), and cells induced with IBMX+DEX and followed with the basic DMEM
were used as the IBMX+DEX control (IBMX+DEX), whereas cells maintained with the basic DMEM medium were used as the negative control (Neg).
Gene expression was evaluated by qRT-PCR, normalized to GAPDH expression and expressed as relative fold change to the positive control. Data
were calculated based on 3 replicates in the same experiment and presented as the means of relative quantification. Error bars represented the
Lower and Upper 95%CI. Each set within the experiment was run in triplicate, and each experiment was performed with at least one additional
run to confirm the repeatability. Statistical analyses among multi-group data were carried out using ANOVA followed by Tukey’s difference test.
* denotes p<0.05; ** denotes p<0.01.
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3.4.4 Effect of lead on signaling and transcriptional cascade of adipogenesis
In this study, when 3T3-L1 cells were induced by the standard differentiation protocol,
the first important transcriptional factor C/EBPβ was activated right after the onset of
differentiation, peaked after 48 hours, and shut down on day 5 (Fig.3.6 A). During the early
induction phase, the activated C/EBPβ initiated the expression of the two terminal transcriptional
regulators C/EBPα and PPARγ around 24 hour-post induction, which maximized at 48 hours post
induction, and was then reduced but continuously expressed during the terminal differentiation
phase (Fig.3.6 B and C). The mature adipocyte marker aP2, which is regulated by PPARγ, was
activated after 24 hours and peaked on day 5 (Fig.3.6 D).
In order to evaluate the effect of lead during adipogenesis, we quantified the mRNA
expression of the four marker genes at different time points: C/EBPβ at 24 and 48 hours; C/EBPα,
PPARγ, and aP2 at 48 hours, on day 5 and day 8. The time points were chosen based on the peak
time of each gene. In experiment Insulin+Pb D3-8, lead was exposed to the cells on day 3,
therefore we only quantified the expression of C/EBPα, PPARγ, and aP2 on day 5 and day 8. On
day 5 lead at all three concentrations significantly suppressed the expression of C/EBPα, PPARγ,
and aP2 (P<0.01). On day 8, concentrations of 1 nM and 100 nM lead were able to upregulate
the expression of C/EBPα and aP2 (Fig.3.7 A).
In experiment Insulin+Pb D0-8, lead was present in cell culture during the entire
experiment period. As shown in Figure 3.7 B, at 48 hours, lead significantly upregulated the
expression of C/EBPβ, C/EBPα and aP2, especially at concentrations of 1 nM and 10 μM (P<0.01).
In the meantime, lead did not affect the expression of PPARγ at all concentrations of lead tested
in this experiment. On day 5, the presence of lead at 1 nM still maintained the capability to
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upregulate C/EBPα and aP2 expression, even though upregulation was only significant for aP2
expression (P<0.01). On the other hand, lead at 100 nM and 10 μM suppressed the expression of
C/EBPα and aP2 in a dose-dependent manner, and 10 μM of lead significantly downregulated
aP2 expression on day 5 (P<0.01). As it relates to PPARγ, all three concentrations of lead showed
a suppressive role (P<0.01). In particular, 10 μM of lead downregulated the expression of PPARγ
to a level similar to the negative control. On day 8, the expressions of C/EBPα, PPARγ, and aP2
were higher than the positive control at lower concentrations, though only the increasing fold of
C/EBPα was statistically significant (P<0.05). The expressions of all three genes remained
suppressed in cells treated with 10 μM of lead. Notably, expression of C/EBPα and PPARγ fell at
levels even lower than the negative control.
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Figure 3.6 Expression of marker genes of adipogenesis during differentiation of 3T3-L1 preadipocytes induced by the standard differentiation
protocol.
Major transcriptional regulators: C/EBPβ (A), C/EBPα (B) and PPARγ (C); mature adipocyte-specific protein: aP2 (D); insulin receptor substrate:
IRS2 (E); and transcriptional factor regulated by insulin: SREBP1c (F) were evaluated. Gene expression was evaluated by qRT-PCR, normalized to
GAPDH expression and expressed as relative fold change to the negative control. Data were calculated based on 3 replicates in the same
experiment and presented as the means of relative quantification. Error bars represented the Lower and Upper 95%CI. Each set within the
experiment was run in triplicate, and each experiment was performed with at least one additional run to confirm repeatability.
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Figure 3.7 continued
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B. Experiment Insulin+Pb D0-8
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Figure 3.7 Effects of lead on marker gene expression during differentiation of 3T3-L1 preadipocytes in
the presence of insulin.
Major transcriptional regulators: C/EBPβ, C/EBPα and PPARγ; mature adipocyte-specific protein: aP2 were
evaluated in experiment Insulin+Pb D3-8 (A) and Insulin+Pb D0-8 (B). Gene expression was evaluated by
qRT-PCR, normalized to GAPDH expression and expressed as relative fold change to the positive control.
Data were calculated based on 3 replicates in the same experiment and presented as the means of relative
quantification. Error bars represented the Lower and Upper 95%CI. Each set within the experiment was
run in triplicate, and each experiment was performed with at least one additional run to confirm the
repeatability. Statistical analyses among multi-group data were carried out using ANOVA followed by
Tukey’s difference test. * denotes p<0.05; ** denotes p<0.01. (Negative: black; Positive: orange; lead 1
nM: grey; 100 nM: yellow; 10 μM: blue)
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In experiment Pb D0-8, insulin was absent during the entire experiment. Instead, lead was
present in the cell culture from day 0 to day 8. In absence of insulin, during the early
differentiation phase, adipogenic gene expressions induced by IBMX+DEX was lower than that
induced by the standard protocol, especially for C/EBPs (Fig.3.8). At 24 and 48 hours, the
presence of lead suppressed the expression of C/EBPβ induced by IBMX+DEX. At 48 hours, the
expression of C/EBPα in lower concentrations of lead-treated cells was suppressed, and this
suppression was significant in cells treated with 100 nM of lead (P<0.05). The expression level of
C/EBPα in 10 μM lead-treated cells was elevated to a level comparable to that exhibited by the
positive control. At 48 hours, PPARγ and aP2 were significantly suppressed by 1 nM and 100 nM
of lead (P<0.01), but were upregulated by 10 μM of lead. In particular, aP2 was upregulated more
than 2.5 fold when compared to the IBMX+DEX control and the positive control (P<0.01). On day
5, C/EBPα was downregulated by lower concentrations of lead (P<0.05), but was robustly
upregulated by 10 μM of lead (P<0.01), compared to the IBMX+DEX control. PPARγ was
suppressed by 1 nM and 100 nM of lead (P<0.05), but was brought to a level similar to the
IBMX+DEX control in 10 μM lead-treated cells. Similar to PPARγ, the expression of aP2 was
significantly downregulated by 1nM and 100 nM of lead (P<0.01), but strongly increased by 10
μM of lead (P<0.01). Both at 48 hours and on day 5, 10 μM of lead showed the highest induction
on gene expression when compared with the two lower concentrations. On day 8, C/EBPα and
aP2 were upregulated by lower concentrations of lead, but aP2 was strongly suppressed by 10
μM of lead. PPARγ was significantly suppressed by all three concentration of lead (P<0.01).
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Figure 3.8 Effects of lead on marker gene expression during differentiation of 3T3-L1 preadipocytes in
the absence of insulin.
Major transcriptional regulators: C/EBPβ, C/EBPα and PPARγ; mature adipocyte-specific protein: aP2 were
evaluated in experiment Pb D0-8. Gene expression was evaluated by qRT-PCR, normalized to GAPDH
expression and expressed as relative fold change to the positive control. Data were calculated based on 3
replicates in the same experiment and presented as the means of relative quantification. Error bars
represented the Lower and Upper 95%CI. Each set within the experiment was run in triplicate, and each
experiment was performed with at least one additional run to confirm the repeatability. Statistical
analyses among multi-group data were carried out using ANOVA followed by Tukey’s difference test. *
denotes p<0.05; ** denotes p<0.01. (IBMX+DEX: green; Positive: orange; lead 1 nM: grey; 100 nM: yellow;
10 μM: blue)

85

The action of insulin is also important during 3T3-L1 adipogenesis. In the 3T3-L1 model,
our results show that the insulin receptor substrate IRS2 started to be upregulated within 8 hours
post-induction, and maximized at 24 hours to then gradually decline (Fig.3.6 E). Conversely,
insulin-regulated transcriptional factor SREBP1c was activated after 24 hours, peaked around 48
hour, then declined to the level of undifferentiated preadipocytes (Fig.3.6 F). Based on the
timeline patterns, the effect of lead on the expressions of insulin related molecules IRS2 and
SREBP1c was evaluated in each experiment: IRS2 at 24 hour and 48 hour and SREBP1c at 24 hour,
48 hour, and on day 5.
In Experiment Insulin+Pb D3-8, lead was exposed to the cells on day 3; therefore, only the
expression of SREBP1c on day 5 was evaluated. In all three concentrations of lead treatment, the
expression of SREBP1c was suppressed when compared to the positive control, but was higher
than the negative control (Fig.3.9 A). Lead at 1 nM and 100 nM significantly suppressed the
SREBP1c expression (P<0.05).
In Experiment Insulin+Pb D0-8, IRS2 expression was suppressed at 8 hours and 24 hours
post-induction in lead-treated cells when compared to the positive control, especially for 100 nM
and 10 μM of lead (P<0.05). Lead at 1 nM exhibited the least suppressive activity on IRS2 at both
time points. At the onset of activation, lead at all concentrations suppressed SREBP1c expression
(P<0.01). At its peak time (48 hours), 1 nM of lead still suppressed its expression (P<0.05), but
100 nM and 10 μM of lead showed a slight increase in SREBP1c expression. On day 5, however,
all three concentrations of lead drastically suppressed SREBP1c expression (P<0.01, Fig.3.9 B).
In Experiment Pb D0-8 (Fig.3.9 C), the absence of insulin resulted in a delayed response
of IRS2 gene activation at 8 hour post-induction, where IRS2 expression in cells treated with
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IBMX+DEX was similar to the negative control. Lead at 1 nM successfully activated IRS2
expression to a similar level of the positive control, while the other 2 doses did not show any
influence. Similar to what observed in Experiment Insulin+Pb D0-8, all three concentrations of
lead significantly suppressed IRS2 expression at 24 hours. Lead also suppressed the expression of
SREBP1c at 24 hours, 48 hours, and on day 5 post-induction, compared to the IBMX+DEX control.
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Figure 3.9 Effects of lead on marker gene expression in insulin signaling pathway during differentiation
of 3T3-L1 preadipocytes.
IRS2 and SREBP1c were evaluated in all three experiments: Experiment Insulin+Pb D3-8 (A), Experiment
Insulin+Pb D0-8 (B), and Pb D0-8 (C). Gene expression was evaluated by qRT-PCR, normalized to GAPDH
expression and expressed as relative fold change to the positive control. Data were calculated based on 3
replicates in the same experiment and presented as the means of the relative quantification. Error bars
represented the Lower and Upper 95%CI. Each set within the experiment was run in triplicate, and each
experiment was performed with at least one additional run to confirm the repeatability. Statistical
analyses among multi-group data were carried out using ANOVA followed by Tukey’s difference test. *
denotes p<0.05; ** denotes p<0.01. (Negative: black; IBMX+DEX: green; Positive: orange; lead 1 nM: grey;
100 nM: yellow; 10 μM: blue)
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3.5

Discussion
Humans have been exposed to the heavy metal lead for a long time. Though the blood

lead level is used as the marker for lead exposure, most of the total body burden is in skeletal
bone and teeth. Although the relationship between lead exposure and obesity has been analyzed
in several studies, both epidemiological and animal studies have reported contradictory results
on lead exposure and obesity, including dose-response relationships, making the interpretation
of the combined data inconclusive. Here in the current study, we used mouse 3T3-L1
preadipocytes to directly identify the effects of lead on adipocyte differentiation and related
dose-response patterns. Our results show that lead upregulates adipogenesis by modulating
transcriptional regulators of adipogenesis C/EBPs and increasing lipid accumulation in mature
adipocytes; however, the higher concentration of lead exposure results in a decreased level of
increased adipogenesis compared with the lower concentration counterparts.
In presence of insulin, both Experiment Insulin+Pb D3-8 and Experiment Insulin+Pb D0-8
show the adipogenic property of lead. Regardless of the exposure time, lead at lower
concentrations robustly increased lipid production after 9-day treatment, whereas lead at 10 μM
induced a lesser level of lipid production when compared with the lower concentrations, but still
higher than the positive control (Fig.3.3). Consistent with the lipid accumulation results,
expression of adipogenic genes on the termination day showed a similar dose-response pattern:
lower concentrations of lead with higher gene expression levels. To our surprise, lead at 10 μM
suppressed the expression of PPARγ and aP2 on day 8 when compared to the positive control,
and the suppressive effect of 10 μM lead was more intense in Experiment Insulin+Pb D0-8 than
in Experiment Insulin+Pb D3-8 (Fig.3.4 A-B). The signaling cascade analysis revealed that lead
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was capable of significantly upregulating C/EBPα and aP2 expression induced by the standard
differentiation cocktail (IBMX, DEX, and insulin) during the early initiation phase of adipogenesis
(P<0.01, Fig.3.7 B). In particular, lead at 10 μM had the strongest additive effect on C/EBPα and
aP2 expression during the early initiation phase. During the terminal differentiation phase (day 5
and day 8), however, the presence of 10 μM lead exerted a continuously suppressive effect on
the marker gene expressions, regardless of the initiation time of lead treatment (Fig.3.7 A-B). The
presence of lead also modulated IRS2 and SREBP1c, the former being the key molecule involved
in insulin signaling and the latter being regulated by insulin and controlling the production of
PPARγ ligand. Both IRS2 and SREBP1c were suppressed by the presence of lead around their peak
times (Fig.3.9 A-B). As a transcriptional regulator of PPARγ ligand, the suppression of SREBP1c on
day 5 might be responsible for the lower expression of PPARγ mRNA by lead treatment on day 5
and day 8 (Fig.3.5 A-B). In the absence of insulin, cells induced by IBMX+DEX exhibited a slower
response of gene activation compared to cells induced by the standard differentiation cocktail
(IBMX+DEX+insulin). When compared to the IBMX+DEX control, the presence of lead still
contributed to increased adipogenesis in regard to lipid accumulation (Fig.3.3). Similar to
Experiment Insulin+Pb, lead at lower concentrations upregulated the expression of C/EBPα and
aP2 on day 8; whereas lead at 10 μM significantly suppressed the expression of PPARγ and aP2
(Fig.3.5 C). The signaling cascade analysis revealed that lead at 10 μM was able to upregulate
C/EBPα and aP2 expression at 48 hours, and maintain the elevated gene expressions until day 5;
then, on day 8, the suppressive effect of lead at 10 μM on the expressions of all three adipogenic
marker genes was observed (Fig.3.8).
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In the current study, we demonstrated two results of lead exposure on adipogenesis using
the mouse 3T3-L1 preadipocyte model. Firstly, lead has adipogenic properties and is able to
directly promote adipocyte differentiation. Our results demonstrate that lead upregulates the
expression of C/EBPs, especially C/EBPα, and aP2 during the early differentiation phase, leading
to the upregulated level of adipogenesis. A study focusing on lead exposure and bone mass
indicated that lead induced inhibition of the Wnt/β-catenin pathway promotes the shift in
mesenchymal differentiation toward an enhanced adipogenesis phenotype (Beier et al. 2013).
Wnt has been demonstrated earlier to be an inhibitor of adipocyte differentiation (Ross et al.
2000). Therefore, lead induced adipogenic marker gene expressions may be principally explained
by the repression of Wnt signaling.
Secondly, and more importantly, our study revealed that lead exerts non-monotonic
dose-dependent responses on adipogenesis. In toxicology, there are two different patterns of
dose-response curves: monotonic and non-monotonic. In the monotonic dose-response pattern,
along with the increased dose, the effect moves only to one direction, either increasing or
decreasing, making a positive or negative slope. In the non-monotonic dose-response pattern,
the dose and effect relationship is complex, and the slope of the curve changes at least once,
resulting in a ‘U’ or inverted ‘U’ shape of curve, or even an undulating curve. In our study, we
found out that persisting exposure of lead at higher concentrations during the terminal
differentiation phase plays a suppressive role on PPARγ and aP2, resulting in a lesser fold of
increased lipid accumulation. This result is consistent with the conclusions from Leasure et al.
(2008) (Beier et al. 2013; Beier et al. 2015)although the experimental design differs in terms of
lead exposure time as well as the experimental model. Beier’s studies focus on the effect of lead
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on bone mass in Long-Evans rats and demonstrate that lifetime exposure of lead in rats results
in increased adipocyte profile in bone marrow composition and increased PPARγ and aP2
expression in the skeleton. These effects appear to be caused by repression of the Wnt/β-catenin
pathway. In their study, Beier et al. also used an in vitro model consisting of C3H10t1/2 mouse
embryonic mesenchymal cells to validate the finding that pre-treatment of lead during the
proliferative phase leads to enhanced adipogenesis in C3H10t1/2 cells. Notably, even though it
was not discussed in the C3H10t1/2 experiment, a significant lower level of C/EBPβ and δ, PPARγ
proteins was observed in 5 μM lead-treated cells versus 1 μM lead-treated cells. Our results, by
using three one-hundred-fold concentrations of lead, confirm the non-monotonic dosedependent response of lead exposure on adipogenesis. Our results may provide a possible
explanation for the findings of Scinicariello’s epidemiological study as well as Leasure’s mice
study, in which they observed that higher level of lead exposure are linked to decreased body
weight/obesity (Leasure et al. 2008; Scinicariello and Buser 2014).
In conclusion, lead appears to promote adipogenesis by upregulating C/EBPα and aP2
expression, indicating its potential role in inducing obesity. However, high concentrations of lead
attenuate the induction of adipogenesis by suppressing PPARγ and aP2 expressions during the
terminal differentiation phase. Therefore, although lead plays a potential role in inducing obesity,
higher concentrations of lead may have an opposite effect.
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4

Chapter 4: High Concentration of Lead Suppresses Adipocyte Differentiation Induced by
2-Naphthol in the 3T3-L1 Model

4.1

Summary
Polycyclic aromatic hydrocarbons (PAHs) and heavy metals are the most abundant air

pollutants. Low-molecular-weight PAHs exert their adverse health effects by mimicking or
antagonizing the action of steroid hormones, whereas heavy metals exhibit their toxicity through
generation of free radicals or by substituting polyvalent cations. Humans are exposed to these
chemicals from the incomplete combustion of oil and gas, tobacco products, vehicle exhaust, and
industry waste. A few published studies address the adverse health effects of co-exposure to
PAHs and heavy metals as it relates to carcinogenesis and DNA damages. However, the co-effects
of these two types of pollutants on adipogenesis and obesity have not been examined yet. In our
previous studies, we have found that the PAH metabolite 2-naphthol (2-NAP) is an accelerator of
adipocyte differentiation. The heavy metal lead (Pb) is also capable of promoting adipogenesis,
but high doses of lead are less effective. Thus, the aim of this study is to evaluate the combined
effects of 2-NAP and lead on adipocyte differentiation, using mouse 3T3-L1 preadipocytes.
3T3-L1 cells were induced by the standard differentiation cocktail containing IBMX, DEX,
and Insulin for the first three days (day 0-2), followed by the DMEM medium containing insulin
alone for six days (day 3-8). 2-NAP and lead, either individually or in combination, were added to
the cell culture from day 3 to day 8. The concentration of each chemical used in this experiment
was 10 μM. Terminal differentiation was evaluated by quantifying the expression of three marker
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genes of adipogenesis: two major transcriptional regulators of terminal adipocyte differentiation
C/EBPα and PPARγ, and the mature adipocyte-specific gene aP2.
After differentiation induced by the standard differentiation cocktail, 2-NAP at 10 μM
upregulated gene expression of C/EBPα, PPARγ and aP2, whereas lead at 10 μM significantly
suppressed PPARγ and aP2 expression. The chemical combination upregulated C/EBPα and
PPARγ. However, upregulation was significant only for PPARγ. When comparing cells treated with
the chemical combination with cells treated with 10 μM of 2-NAP, a decreased level of mRNA
expressions in all three marker genes was observed. In particular, C/EBPα expression was greatly
affected by the 2-NAP+lead combination. Compared with cells treated with 10 μM of lead alone,
gene expression levels of PPARγ and aP2 were significantly enhanced in 2-NAP and lead cotreated cells.
Altogether, these results suggest that lead at a higher concentration plays a suppressive
role on 2-NAP induced adipocyte differentiation, indicating the existence of joint effects between
the PAH metabolite 2-NAP and the heavy metal lead. Therefore, although exposure to lowmolecule-weight PAHs is demonstrated to be associated with higher body mass index and
obesity, co-exposure to higher concentrations of lead could counterbalance the effect of PAHs.

4.2

Introduction
Humans and other organisms are exposed to a variety and mixtures of environmental

pollutants. In air polluted by tobacco products, industry waste, and car emissions, there is a large
amount of PAHs and heavy metals (Bae et al. 2010). Numerous studies have reported the adverse
effects of exposure to PAHs (ATSDR 1995) or heavy metals (Tchounwou et al. 2012). The currently
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available literature on the toxic effects of co-exposure to these two types of pollutants on human
health reveals additive, synergistic, or suppressive effects. However, co-exposure studies of PAH
and heavy metals mostly focus on carcinogenesis and DNA damage (Haguenoer et al. 1996;
Huang et al. 2013; Vakharia et al. 2001). Little is known about the interactive effects of these two
types of pollutants on obesity.
Results from our previous studies (Chapter 2 and 3) highlight the effects of individual 2NAP and lead exposure on adipogenesis: 2-NAP and low concentrations of lead are capable of
accelerating the adipogenesis process in 3T3-L1 cells, whereas lead at high concentration (10 μM)
suppresses adipogenesis. Therefore, we hypothesized that exposure to lead at a high
concentration down-modulates the adipogenesis-inducing effects of exposure to 2-NAP.

4.3

Materials and Method

4.3.1 Materials
Mouse embryo fibroblast 3T3-L1 cells (ATCC CL-173, lot 59796011) and bovine calf serum
(ATCC, 30-2030) were obtained from ATCC. Dulbecco’s modified Eagle’s medium (DMEM)
(Cellgro 10-013CV) and 100X penicillin- streptomycin solution (Cellgro 30-002-CI) were purchased
from Mediatech, Inc. Human insulin solution (I9278), dexamethasone (D2915), 3-Isobutyl-1methylxanthine (I5879), formalin solution (HT501128), and Oil Red O (O0625) were obtained
from Sigma-Aldrich Co. LLC. Lead acetate solution (SL9000-250) was purchased from Fisher
Scientific Co, and 2-Naphthol was obtained from Acros Organics. In this study, lead acetate was
used as the source for all lead exposure experiments.
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4.3.2 Experimental design
To test whether lead at 10 μM plays a suppressive role on adipogenesis induced by 2NAP, we exposed 3T3-L1 cells induced by standard differentiation medium to the mixture of
these two chemicals from day 3 to day 8 (Fig.4.1) and evaluated gene expression of the three
markers at day 8.
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A. Standard differentiation protocol for 3T3-L1 cells (Positive control protocol)

B. chemical exposure protocol

1) 2-NAP:

2) Lead:

3) The chemical combination:

Figure 4.1 Protocols for adipogenic differentiation and chemical exposure in 3T3-L1 cells.
Cells were differentiated after confluence (designated as day 0, indicated by the first black arrow) by
replacing the basic DMEM medium with the differentiation medium for three days. The concentrations of
each component in the differentiation medium were 0.5 mM for IBMX, 0.25 μM for dexamethasone (DEX)
and 1 μg/mL for insulin. Cell cultures were exposed to 10 μM of 2-NAP or lead, or to the combination of
10 μM 2-NAP and lead from day 3 to day 8 in the presence of 1 μg/mL insulin. Curly brackets indicated
the chemical exposure period.
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4.3.3 Cell culture and differentiation
3T3-L1 cells were cultured in the DMEM medium supplemented with 10% bovine calf
serum (BCS), 100 I.U. penicillin and 100 μg/mL streptomycin. Cells were grown in 75 cm 2 culture
flasks in a humidified atmosphere with 5% CO2 at 37 °C and subcultured when they became 80%
confluent.
Cells were seeded at a density of 6x104 cells/well in Costar 6-well plates with the basic
DMEM medium. After reaching confluency (Day 0), cell differentiation was induced by replacing
the basic DMEM medium with the differentiation medium containing 0.5 mM IBMX, 0.25 μM
DEX, and 1 μg/mL insulin for three days (day 0 to day 2). On day 3, the differentiation medium
was replaced with the DMEM medium containing 1 μg/mL insulin in the presence or absence of
10 μM 2-NAP, 10 μM lead, or the combination of 10 μM 2-NAP and 10 μM lead. 3T3-L1 cells
maintained with DMEM medium were used as negative control.
4.3.4 Quantitative real-time reverse transcription-polymerase chain reaction (Real-Time
PCR)
Total RNA was extracted from cells using QIAGEN RNeasy Plus Mini Kit (Qiagen Inc.,
Valencia, CA). Using High-Capacity cDNA reverse transcription kit (Applied Biosystems), 5 μL of
the total RNA was reverse-transcribed into cDNA. The reaction mixture contained 1x reverse
transcriptase buffer, 4 mM dNTP (deoxynucleotide triphosphate), 5x Random primers, 1 U RNase
inhibitors, and 2.5 U of MultiScribe Reverse Transcriptase. The RT-PCR was performed with the
following cycle parameters: 25°C for 10 min, 37°C for 120 min, and 85°C for 5 min. Synthesized
cDNA was diluted with RNase-free water. Then, quantitative real-time PCR amplification was
performed with appropriate sets of primers using Taqman gene expression assays in a total
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volume of 20 μL that contained aliquoted cDNA samples. Gene expression assays were carried
out with the following cycle parameters: 55°C for 2min; 94°C for 10 min; 40 cycles of 94°C for 15
sec and 60°C for 60 sec. The following primers and probes were obtained from Applied
Biosystems: C/EBPα (Mm00514283_s1); PPARγ (Mm01184322_m1); aP2 (Mm00445878_m1);
and housekeeping gene GAPDH (Cat: 4352339E), as an endogenous control to correct the
variation of RNA and cDNA loading. Data were analyzed using the ΔCT method. Target gene
expression was normalized to GAPDH for ΔCT value, then calibrated to the control sample in each
experiment to give the ΔΔCT value. Data were calculated based on three replicates in the same
experiment and presented as the means of relative quantification. Error bars represented the
Lower and Upper 95% Confidence Interval. Each set of the experiment was run in triplicate, and
each experiment was performed with an additional run to confirm the repeatability.
4.3.5 Statistical analysis
Statistical analysis among multi-group data were carried out using ANOVA followed by
the Tukey’s difference test. P < 0.05 was considered significant. Each experiment was repeated
twice, and each set of the experiments were run in triplicates.

4.4

Results

4.4.1 The co-effect of 2-NAP and lead on marker gene expressions of adipogenesis
As shown in Figure 4.2, consistent with our previous experiments, on the termination day,
2-NAP at 10 μM drastically upregulated the gene expression of C/EBPα, PPARγ, and aP2 (P<0.01).
In addition, lead at 10 μM significantly suppressed the expression of PPARγ and aP2 (P<0.01). The
chemical combination was still capable of upregulating C/EBPα and PPARγ to 1.7 and 1.6 fold
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respectively, even though it was only significant for PPARγ (P<0.01). A significantly decreased
level of mRNA expression of all three genes was observed in cells treated with the chemical
combination when compared with cells treated with 10 μM of 2-NAP (P<0.01). C/EBPα expression
was greatly affected by 2-NAP and lead combination which, together, were reduced from 5.6 fold
in 10 μM of 2-NAP treated cells to 1.7 fold in chemical combination treated cells. The lead
suppressive effect on 2-NAP-induced PPARγ and aP2 expression was less intense, but the
difference was still significant (P<0.01). Compared with cells treated with 10 μM of lead, gene
expression levels of PPARγ and aP2 were significantly upregulated in 2-NAP and lead co-treated
cells (P<0.01). Two fold of increasing PPARγ expression was observed between the lead-only and
the chemical combination treatments, from 0.74 fold to 1.56 fold (P<0.01). Similar to PPARγ, aP2
expression was also slightly but significantly upregulated (P<0.01). Taken together, these results
suggest that 10 μM of lead significantly suppresses the adipogenesis induced by 10 μM of 2-NAP,
indicating the existence of joint effects between the PAH metabolite 2-NAP and heavy metal lead.
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Figure 4.2 Effects of 2-naphthol in the presence of lead on adipogenic gene expression at day 8 of 3T3L1 differentiation.
Major transcriptional regulators in terminal adipocyte differentiation: C/EBPα and PPARγ; mature
adipocyte-specific protein: aP2. Post-confluent 3T3-L1 cells were induced to differentiate into adipocytes
by the standard differentiation protocol, with 0.5 mM IBMX, 0.25 µM DEX and 1 µg/mL insulin for 3 days
followed by 1 µg/mL insulin for six days. Cells were exposed to the individual chemicals or the mixture of
10 μM 2-NAP and 10 μM from day 3 to day 8. Cells treated with 0.5 mM IBMX, 0.25 µM DEX and 1 µg/mL
insulin for 3 days followed by 1 µg/mL insulin were used as positive control (Pos), whereas cells maintained
with DMEM medium were used as negative control (Neg). Gene expression was evaluated by qRT-PCR,
normalized to GAPDH expression and expressed as relative fold change to the positive control. Data were
calculated based on three replicates in the same experiment and presented as the means of relative
quantification. Error bars represented the Lower and Upper 95% confidence interval. Each set of the
experiment was run in triplicate, and each experiment was performed with an additional run to confirm
the repeatability. Statistical analyses among multi-group data were carried out using ANOVA followed by
Tukey’s difference test. * denotes p<0.01.
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4.5

Discussion
Humans and other organisms are exposed to a variety and mixtures of environmental

pollutants. PAHs and heavy metals are the most abundant components of air pollution. Coexposure to these two may result from smoking or secondary smoking, car emissions from heavy
traffics, coal production-related industry waste or occupational exposure (Bae et al. 2010). Coexposure studies of PAH and heavy metals are very scarce and mostly focus on carcinogenesis
and DNA damage. Little is known about the interaction effects between these two types of
pollutants on obesity. Therefore, the current study was designed to test the co-effect of 2-NAP
and lead on adipogenesis in mouse 3T3-L1 preadipocytes. Our results show evidence that lead at
a higher concentration plays a suppressive role on 2-NAP induced adipogenesis, indicating an
attenuated acceleration of adipocyte differentiation when co-exposed to high concentrations of
2-NAP and lead.
In general, additive, synergistic, and suppressive effects are the three possible patterns
of interactions between two chemicals. The additive and suppressive toxic co-effects have
already been reported between PAHs and heavy metals. Haguenoer et al. described the additive
effects of PAHs and heavy metals in an animal study, demonstrating that iron oxides can induce
lung cancer only when benzo(a)pyrene is co-administered (Haguenoer et al. 1996). Another
epidemiological study that focuses on the exposure to traffic-related air pollutants suggests the
additive effects of the PAH metabolite 1-hydroxypyrene-glucuronide (1-OHPG) and cadmium on
increasing levels of oxidative stress (Huang et al. 2013). Suppressive effects of PAHs and heavy
metals have also been reported. The heavy metal arsenic, lead, mercury, and cadmium efficiently
decrease the CYP1A1/1A2 bioactivation induced by PAHs in human hepatocyte cultures (Vakharia
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et al. 2001). Our previous results (Chapter 2 and Chapter 3) indicate that both 2-NAP and selected
lead concentrations are capable of upregulating adipogenesis. However, when tested in
combination in the study described in this Chapter (Chapter 4), no additive effects were observed
In contrast, exposure to 10 μM of lead during the terminal differentiation phase counterbalanced
the increased effect of 2-NAP on adipocyte differentiation, leading to a decreased level of
promoted adipogenesis induced by the chemical combination.
This joint effect of 2-NAP and lead on adipocyte differentiation might result from different
mechanisms of action used by these two chemicals. In the previous chapters, we demonstrated
that 2-NAP induces adipogenesis by modulating the expression of the master transcriptional
regulator PPARγ as well as molecules involve in the insulin signaling pathway. 2-NAP at 10 μM
exhibited the greatest impact on marker gene expressions and phenotypic markers of
adipogenesis. The effect of 2-NAP on adipogenesis might tightly associate with its endocrine
disrupting capability. On the other hand, we also demonstrated that lead plays an upregulating
role on adipogenesis, even though the dose-response of lead is non-monotonic. The induction of
adipogenesis by lead results from the upregulation of CEBPs during the early differentiation
phase; however, lead also plays a suppressive role on PPARγ and aP2 expression and
mitochondrial activities during the terminal differentiation phase. Even though the detailed
mechanisms of action of 2-NAP and lead need to be explored, results from the current study
provide evidence that 2-NAP and lead may contribute to the overall adipogenesis induced by the
chemical combination via independent pathways, and may counterbalance the roles of each
other on the expression of adipogenic genes.
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In conclusion, lead at a higher concentration plays a suppressive role on 2-NAP-induced
adipocyte differentiation, demonstrating a suppressive co-effect of the PAH metabolite 2-NAP
and the heavy metal lead on adipogenesis. This result indicates that although exposure to lowmolecule-weight PAH associates with higher body mass index and obesity, co-exposure to higher
concentrations of lead could counterbalance the effect of PAHs. Therefore, joint effects of
different chemical mixtures should be taken into consideration in studies that focus on the
adverse effects of environmental pollutants.
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5

Chapter 5: The effect of environmental pollutants on anti-microbial peptide production
during adipocyte differentiation

5.1

Summary
Adipocytes play important roles in the host innate immune response. At the site of

infection, adipocytes secrete cytokines to recruit immune cells such as macrophages and
neutrophils. On the other hand, preadipocytes, upon activation of pathogens, start to
differentiate into mature adipocytes. In the meantime, these differentiating adipocytes produce
anti-microbial peptides (AMPs) which immediately protect the host from pathogens before the
recruitment of other immune cells. In our previous study, we demonstrated that environmental
pollutants 2-naphthol (2-NAP) and lead (Pb) are capable of moderating preadipocyte
differentiation. Therefore, we hypothesized that environmental pollutants might have an impact
on the innate immune response by modulating the production of AMPs in differentiating
adipocytes.
To test the hypothesis, we used an in vitro model of mouse 3T3-L1 preadipocytes. 3T3-L1
cells were induced by the standard differentiation cocktail with IBMX, DEX, and insulin for the
first three days (day 0-2), followed by DMEM medium containing only insulin for six days (day 38). Cell cultures were exposed to the chemicals from day 3 to day 8. Bisphenol A (BPA) at 100 nM,
three one-hundred-fold concentrations of 2-NAP or lead (1 nM to 10 μM), or the combination of
2-NAP and lead at 10 μM were tested. The production of one of AMPs cathelicidin (Camp) mRNA
was evaluated by quantitative PCR on the termination day.
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Compared with preadipocytes, Camp mRNA expression was significantly activated during
adipocyte differentiation. BPA, a known obesogen, was able to upregulate Camp expression. 2NAP elevated the production of Camp mRNA in a dose-dependent manner. In particular, 2-NAP
at 10 μM drastically upregulated the expression of Camp. Lead, on the other hand, slightly
induced the expression of Camp mRNA at lower concentrations, whereas 10 μM of lead
suppressed Camp expression. The combination at 10 μM of both 2-NAP and lead did not result
in a co-effect on the expression of Camp. In comparing cells treated with the chemical
combination to cells treated with 10 μM of 2-NAP, a decreased level of Camp mRNA expression
was observed. Compared with cells treated with 10 μM of lead, the gene expression level was
significantly enhanced in 2-NAP and lead co-treated cells.
In conclusion, BPA and 2-NAP, as inducers of adipocyte differentiation, enhance the
production of Camp in differentiating adipocytes. Similar to the effect on adipogenesis, lead
upregulates Camp production at lower concentrations, but suppresses it at higher
concentrations. Moreover, lead at a higher concentration plays a suppressive role on 2-NAPinduced Camp production during adipocyte differentiation. Therefore, environmental pollutants
that are capable of influencing adipogenesis appear to also modulate production of Camp in
differentiating adipocytes, thus potentially playing a role in modulating inflammation status and
innate immune responses.

5.2

Introduction
Cathelicidins, one of the most abundant types of AMPs, are a family of evolutionarily

conserved peptides with antibacterial, antiviral, and antifungal activities in reptiles, fish, birds
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and mammals (Bucki et al. 2010; Doss et al. 2010). Cathelicidins consist of an N-terminal signal
sequence, a conserved cathelin-like domain, and a C-terminal antimicrobial domain (Zanetti et
al. 1995). While some mammals have multiple forms of cathelicidins (for example bovine
cathelicidins: BMAP28, Bac 5, and indolicidin) (Chan et al. 2006), humans and mice each only
produce one cathelicidin, named LL-37/hCAP18 and mCRAMP, respectively (Cowland et al. 1995;
Gallo et al. 1997; Larrick et al. 1994).
The gene that encodes human cathelicidin LL-37 contains four exons and lies on
chromosome 3 (Gudmundsson et al. 1996; Larrick et al. 1996), and the mature peptide consists
of 37 amino acids. LL-37 is secreted by epithelial cells and leukocytes, especially lymphocytes and
monocytes (Agerberth et al. 2000; Bals et al. 1998). Due to the amphipathic α-helix structure and
the positive charge, cathelicidins directly kill bacteria by forming pores on the cell membranes
(Lee et al. 2011). Besides the direct antimicrobial ability, cathelicidins function in stimulating
wound healing and participate in immune responses. Research on human cathelicidins suggests
that LL-37 is strongly expressed in healing epithelium cells in the skin (Heilborn et al. 2003). LL37 induces re-epithelization by serving as a pro-migratory factor. This action is mediated through
the STAT3 pathway in an EGFR-dependent manner, resulting in increased migration of
keratinocytes (Tokumaru et al. 2005). The rat cathelicidin has also been demonstrated to
participate in healing of stomach ulcers by stimulating the proliferation of gastric epithelial cells
(Yang et al. 2006). The action of rat cathelicidin in promoting gastric epithelial cells proliferation
depends on the TGF-α activated MEK/ERK signaling pathway. Altogether, the ability to promote
cell proliferation, migration, and angiogenesis shows that cathelicidin is an important factor in
wound healing.
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In addition, cathelicidins have immunomodulatory properties and can function as
leukocytes chemoattractants, regulating neutrophil, monocyte, mast cell, and CD4+ T
lymphocyte migration to and infiltration into the inflammatory sites through a G protein coupled
transmembrane cell receptor named formyl-peptide receptor-like 1 (De Yang et al. 2000).
Moreover, cathelicidins can regulate cytokine and chemokine production in several cell types. LL37 induces the production of IL-8 in epithelial cells resulting in the recruitment of neutrophils and
increased inflammations (Tjabringa et al. 2003). The production of other pro-inflammatory
mediators, such as IL-1β, COX-2, and IL-6 by keratinocytes (Braff et al. 2005) and CXCL8 and CCL2
by macrophages (Huang et al. 1997), have also been reported to be modulated by LL-37.
The study of Ling-juan Zhang revealed an important role of differentiating adipocyte on
host defense against bacteria infection. Upon skin infection, accompanied with the local
expansion of adipocytes, the increasing production of Camp from differentiating adipocytes
protects the host before the recruitment of innate immune cells (Zhang et al. 2015).
In previous studies, we demonstrated that 2-NAP and lead, individually and in
combination, were capable of modulating the process of adipocyte differentiation. Here, we
aimed to identify whether environmental pollutants modulate Camp production while
modulating adipocytes differentiation.

5.3

Materials and methods

5.3.1 Materials
Mouse embryo fibroblast 3T3-L1 cells (ATCC CL-173, lot 59796011) and bovine calf serum
(ATCC, 30-2030) were obtained from ATCC. Dulbecco’s modified Eagle’s medium (DMEM)
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(Cellgro 10-013CV) and 100X penicillin- streptomycin solution (Cellgro 30-002-CI) were purchased
from Mediatech, Inc. Human insulin solution (I9278), dexamethasone (D2915), 3-Isobutyl-1methylxanthine (I5879), formalin solution (HT501128), bisphenol A (BPA, 239658), and Oil Red O
(O0625) were obtained from Sigma-Aldrich Co. LLC. Lead acetate solution (SL9000-250) was
purchased from Fisher Scientific Co, and 2-Naphthol was obtained from Acros Organics. In this
study, lead acetate was used as the source for all lead exposure experiments.
5.3.2 Experimental design
In the current study, 3T3-L1 cells were induced to differentiate by the standard
differentiation protocol, and cells were exposed to individual chemicals or the combination of 2NAP and lead from day 3 to day 8 (Fig.5.1). The mRNA expression of Camp was evaluated on the
termination day. BPA was used as a known environmental pollutant that induces 3T3-L1
adipogenesis.
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A. Standard differentiation protocol for 3T3-L1 cells (Positive control protocol)

B. Chemical exposure protocol
1) Individual chemical: BPA, 2-NAP and lead

2) The chemical combination: 2-NAP+Pb

Figure 5.1 Protocols for adipogenic differentiation and chemical exposure in 3T3-L1 cells.
Cells were differentiated after confluence (designated as day 0, indicated by the first black arrow) by
replacing the basic DMEM medium with the differentiation medium for three days. The concentrations of
each component in the differentiation medium were 0.5 mM for IBMX, 0.25 μM for dexamethasone (DEX)
and 1 μg/mL for insulin. Individual BPA, 2-NAP, or lead, or the combination of 10 μM 2-NAP and lead were
exposed to the cell culture from day 3 to day 8 in the presence of 1 μg/mL insulin. Curly brackets indicated
the chemical exposure period.
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5.3.3 Cell culture and differentiation
3T3-L1 cells were cultured in DMEM medium supplemented with 10% bovine calf serum
(BCS), 100 I.U. penicillin and 100 μg/mL streptomycin. Cells were grown in 75 cm 2 culture flasks
in a humidified atmosphere with 5% CO2 at 37 °C and subcultured when they became 80%
confluent.
Cells were seeded at a density of 6x104 cells/well in Costar 6-well plates with the basic
DMEM medium. After confluent (Day 0), cell differentiation was induced by replacing the basic
DMEM medium with the differentiation medium containing 0.5 mM IBMX, 0.25 μM DEX, and 1
μg/mL insulin for three days (day 0 to day 2). On day 3, the differentiation medium was replaced
with the DMEM medium with 1 μg/mL insulin in the presence or absence of BPA, 2-NAP, lead, or
2-NAP and lead mixture. The concentrations of each chemical used in this experiment were, 100
nM for BPA; 1 nM, 100 nM, and 10 μM for 2-NAP; 1 nM, 100 nM, and 10 μM, or the combination
of 10 μM 2-NAP and 10 μM lead. 3T3-L1 cells maintained with the DMEM medium were used as
negative control.
5.3.4 Quantitative real-time reverse transcription-polymerase chain reaction (Real-Time
PCR)
Total RNA was extracted from cells using the QIAGEN RNeasy Plus Mini Kit (Qiagen Inc.,
Valencia, CA). Using the High-Capacity cDNA reverse transcription kit (Applied Biosystems), 5 μL
of total RNA was reverse-transcribed into cDNA. The reaction mixture contained 1x reverse
transcriptase buffer, 4 mM dNTP (deoxynucleotide triphosphate), 5x Random primers, 1 U RNase
inhibitors, and 2.5 U of MultiScribe Reverse Transcriptase. The RT-PCR was performed with the
following cycle parameters: 25°C for 10 min, 37°C for 120 min, and 85°C for 5 min. Synthesized
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cDNA was diluted with RNase-free water. Then, quantitative real-time PCR amplification was
performed with appropriate sets of primers using Taqman gene expression assays in a total
volume of 20 μL that contained aliquot cDNA samples. Gene expression assays were carried out
with the following cycle parameters: 55°C for 2min; 94°C for 10 min; 40 cycles of 94°C for 15 sec
and 60°C for 60 sec. The following primers and probes were obtained from Applied Biosystems:
C/EBPα (Mm00514283_s1); PPARγ (Mm01184322_m1); aP2 (Mm00445878_m1); Camp (Assay
ID: Mm00438285_m1); and housekeeping gene GAPDH (Cat: 4352339E), as an endogenous
control to correct the variation of RNA and cDNA loading. Data were analyzed using the ΔCT
method. Target gene expression was normalized to GAPDH for ΔCT value, then calibrated to the
control sample in each experiment to give the ΔΔCT value. Data were calculated based on three
replicates in the same experiment and presented as the means of relative quantification. Error
bars represented the Lower and Upper 95% Confidence Interval. Each set of the experiment was
run in triplicate, and each experiment was performed with an additional run to confirm the
repeatability.
5.3.5 Statistical analysis
Statistical analyzes among multi-group data were carried out using ANOVA followed by
Tukey’s difference test. P < 0.05 was considered significant. Each experiment was repeated twice,
and each set of the experiments were run in triplicates.
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5.4

Results

5.4.1 The effect of 2-NAP and lead on Camp production
The adipogenic property of BPA has been well studied in both cell lines and animal models
including mouse 3T3-L1 cells. Consistent with others studies, Figure 5.2 shows that 100 nM of
BPA was able to significantly elevate the expression of aP2 when compared with the positive
control (P<0.01), indicating its additive role on adipogenesis. Moreover, 100 nM of BPA was also
able to significantly upregulate Camp production on day 8 (P<0.01).
As shown in Figure 5.3 A, 2-NAP upregulated the mRNA expression of Camp in a dosedependent manner. Even though at the lower concentrations (1 nM and 100 nM) the effect of 2NAP on upregulating Camp production was quite weak (1.4 and 1.5 fold of increase, P<0.01), 2NAP at 10 μM exhibited a significant impact on Camp production (P<0.01). On the other hand,
depending on the concentrations, lead played different roles on Camp production (Fig.5.3 B). At
lower concentrations (1 nM and 100 nM), lead significantly upregulated the expression of Camp
in an inverse dose-response manner (P<0.01), in which 1 nM of lead was capable of inducing a
higher production of Camp than 100 nM of lead. At a higher concentration (10 μM), lead
suppressed the expression of Camp (P<0.01). As it relates to the chemical combination (2-NAP
and lead at 10 μM), the difference in Camp production in 3T3-L1 cells between the positive
control and the chemical combination was not significant (Fig.5.3 C). Compared with cells treated
with individual chemicals, however, the difference was statistically significant (P<0.01), indicating
that the suppressive role of lead at 10 μM counterweighed the effect of 2-NAP at 10 μM on
inducing Camp production
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Taken together, these results suggest that modulation of adipocyte differentiation by 2NAP and lead may in turn regulate Camp production. Alternatively, the two chemicals may
directly modulate Camp production.
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Figure 5.2 Effects of BPA on adipogenic gene and Camp expressions.
Major transcriptional regulators in terminal adipocyte differentiation: C/EBPα and PPARγ; mature
adipocyte-specific protein: aP2; mouse antimicrobial peptide Cathelicidin: Camp. Post-confluent 3T3-L1
cells were induced to differentiate into adipocytes by the standard differentiation protocol, with 0.5 mM
IBMX, 0.25 µM DEX and 1 µg/mL insulin for 3 days followed by 100 nM BPA and 1 µg/mL insulin for six
days. Cells treated with 0.5 mM IBMX, 0.25 µM DEX and 1 µg/mL insulin for 3 days followed by 1 µg/mL
insulin were used as positive control (Pos), whereas cells maintained with DMEM medium were used as
negative control (Neg). Gene expression was evaluated by qRT-PCR, normalized to GAPDH expression and
expressed as relative fold change to the positive control. Data were calculated based on three replicates
in the same experiment and presented as the means of relative quantification. Error bars represented the
Lower and Upper 95% confidence interval. Each set of the experiment was run in triplicate, and each
experiment was performed with an additional run to confirm the repeatability. Statistical analyses among
multi-group data were carried out using ANOVA followed by Tukey’s difference test. * denotes p<0.01.
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Figure 5.3 Effects of 2-NAP and lead on Camp expression.
Mouse antimicrobial peptide Cathelicidin: Camp. Post-confluent 3T3-L1 cells were induced to differentiate
into adipocytes by the standard differentiation protocol, with 0.5 mM IBMX, 0.25 µM DEX and 1 µg/mL
insulin for 3 days followed by 1 µg/mL insulin for six days. Individual 2-NAP, lead, or the mixture of 10 μM
2-NAP and 10 μM lead were exposed to the cells from day 3 to day 8. Cells treated with 0.5 mM IBMX,
0.25 µM DEX and 1 µg/mL insulin for 3 days followed by 1 µg/mL insulin were used as positive control
(Pos), whereas cells maintained with DMEM medium were used as negative control (Neg). Gene
expression was evaluated by qRT-PCR, normalized to GAPDH expression and expressed as relative fold
change to the positive control. Data were calculated based on three replicates in the same experiment
and presented as the means of relative quantification. Error bars represented the Lower and Upper 95%
confidence interval. Each set of the experiment was run in triplicate, and each experiment was performed
with an additional run to confirm the repeatability. Statistical analyses among multi-group data were
carried out using ANOVA followed by Tukey’s difference test. * denotes p<0.01.
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5.5

Discussion
AMPs are a group of small-molecular-weight proteins secreted by epithelial cells,

keratinocytes, Paneth cells, and immune cells, and have antimicrobial activities that can target a
broad spectrum of pathogens. Moreover, AMPs are produced by plants, insects, vertebrates and
mammals, and are thus considered an ancient component of innate immunity (Wiesner and
Vilcinskas 2010). Adipocytes have been reported to play important roles in regulating the host
immune response by producing cytokines and adipokines that recruit immune cells. A recent
study has added another vital role of adipocytes in innate immunity: differentiating adipocytes
secrete AMPs to kill bacteria directly, thus participating in the first-line of defense against
infection (Zhang et al. 2015). Numerous studies have reported the adipogenic effects of a variety
of environmental pollutants, as well as their modulating roles on cytokine/adipokine
productions; however, none of them have been tested for AMP productions in adipocytes. In the
current study, we demonstrated that BPA, 2-NAP and lead, which affect adipocyte
differentiation, have the capability of influencing the production of the AMP Camp in
differentiating adipocytes, indicating potential immunomodulatory properties of these three
environmental pollutants. BPA and 2-NAP are capable of upregulating Camp expression during
the terminal differentiation phase, while lead upregulates Camp expression at lower
concentrations, but suppresses it at higher concentrations. In addition, the mixture of 2-NAP and
lead at higher concentrations counterweighs their individual additive or suppressive effects,
consequently showing no net co-effect on Camp production.
Cathelicidins are one of the major groups of mammalian AMPs. These evolutionarily
conserved ancient types of AMPs contain an N-terminal signal sequence, a conserved cathelin-
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like domain, and a C-terminal antimicrobial domain (Zanetti et al. 1995). Humans and mice only
produce one cathelicidin, named LL-37/hCAP18 and CRAMP, respectively (Cowland et al. 1995;
Gallo et al. 1997; Larrick et al. 1994). Cathelicidins not only have direct antimicrobial ability, but
also show other types of functions in immune modulation (De Yang et al. 2000; Huang et al.
1997), angiogenesis (Koczulla et al. 2003; Li et al. 2000), and wound healing (Heilborn et al. 2003;
Yang et al. 2006). This study, for the first time, suggests that selected environmental pollutants
(BPA, 2-NAP and lead) modulate the production of antimicrobial peptides in adipocytes. BPA at
100 nM was capable of elevating Camp expression on the termination day. Similar to what
observed in our adipogenesis-related studies, both 2-NAP and lead induced specific doseresponse patterns of Camp expressions when individually exposed to 3T3-L1 cells: 2-NAP
upregulated Camp in a dose-dependent manner, while lead upregulated Camp only at lower
concentrations, but suppressed its expression at high concentration. Camp has been shown to
serve as a chemoattractor for leucocytes and regulate the expression of pro-inflammatory
cytokines and chemokines (Agerberth et al. 2000; De Yang et al. 2000; Niyonsaba et al. 2002;
Qian et al. 2015; Scott et al. 2002), suggesting its role in generating a chronic inflammation status.
Therefore, the modulated production of Camp by environmental pollutants with adipogenic
potentials may contribute to an inflammatory status in adipose tissues, providing a novel link
between innate immunity and environmental pollutants.
In conclusion, BPA, 2-NAP, and lead, which interfere with adipogenesis, modify the
expression of AMPs during adipocytes differentiation in a fashion similar to that we have
observed for the adipogenic genes. These findings will help to design future studies to investigate
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the role that environmental pollutants play in the development of inflammation/immunemediated diseases and overweight/obesity.
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6

Chapter 6: Conclusions

Environmental pollution is an increasing global issue. Humans are exposed to
environmental pollutants mainly via drinking water, food, air, and, to a lesser extent, via skin
contact. Numerous studies have shown epidemiological relationships between exposure to
environmental pollutants and a wide range of diseases in humans. In addition, direct adverse
health effects of exposure to a variety of environmental pollutants have been shown using in
vitro and in vivo research models.
Exposure to selected environmental pollutants has been linked to obesity, a global
pandemic disease that affects both adults and children. For example, Bisphenol A (Masuno et al.
2005) and phthalates (Hao et al. 2012) appear to promote adipogenesis and obesity, whereas
cadmium (Lee et al. 2012) seems to inhibit it. Many more pollutants remain to be tested. In this
study, we determined the adipogenic properties of two chemicals of unknown obesogenic
potential, the PAH 2-naphthol and the heavy metal lead. In addition, we assessed, their effects
on antimicrobial peptide production during adipogenesis.
Our results show that both 2-NAP and lead exert adipogenic properties in vitro, suggesting
their potential role in inducing obesity. Indeed, 2-NAP exerts its effect on 3T3-L1 preadipocyte
differentiation in a dose-dependent manner. As low as 100 pM of 2-NAP is capable of
upregulating the master transcriptional regulators C/EBPα and PPARγ. Furthermore, we found
that even in the absence of insulin, 2-NAP at concentrations of 100nM and higher is able to
successfully accelerate the differentiation process. The finding that 2-NAP increases the
expression levels of PPARγ, IRS2, and SREBP1c indicate that 2-NAP contributes to 3T3-L1
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differentiation via modulation of the PPARγ pathway, and IRS2 and SREBP1c molecules in the
insulin pathway. On the other hand, our results show that lead is capable of increasing
adipogenesis in the mouse 3T3-L1 model following a non-monotonic curve. Lead upregulates
adipogenesis by significantly elevating the expression of C/EBPα and aP2 during the early
differentiation phase. This early effect might result from the ability of lead to suppress the Wnt/βcatenin pathway (Beier et al. 2013). Interestingly, lower concentrations of lead are able to sustain
upregulation of C/EBPα and aP2 during terminal differentiation, whereas higher lead
concentrations exert a suppressive role on PPARγ and aP2 expression, resulting in lower
increased adipogenesis when compared to the lower concentrations. Further studies will explore
the mechanism of action by which 2-NAP and higher concentrations of lead influence terminal
differentiation.
PAHs and lead co-exist in polluted air deriving from industry waste, vehicle exhaust,
tobacco products, and incomplete combustion of oil and gas. High levels of exposure to PAHs and
lead are often occupational, occurring for example among mine and road construction workers,
and traffic conductors. Exposure is also common in smoking populations (Bae et al. 2010; Huang
et al. 2013; Wang et al. 2015). We have shown that co-exposure to high concentrations of 2-NAP
and lead results in a weak net effect on 3T3-L1 adipogenesis compared to 2-NAP exposure alone.
The suppressive role of lead at high concentrations during the terminal differentiation phase
counterbalances the effect of 2-NAP in inducing adipogenesis. This co-effect suggests that 2-NAP
and lead may utilize independent pathways to modulate the key transcriptional regulators PPARγ
and C/EBPα and their downstream adipogenic genes. Furthermore, the no net effect also
suggests that though both 2-NAP and lower doses of lead are able to upregulate the expression
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of PPARγ, C/EBPα, and aP2, the combination of 2-NAP and lead at high concentrations do not
result in an additive effect.
It is important to note that differentiating adipocytes produce cathelicidins, as recently
demonstrated by Zhang et al. (2015). Cathelicidins are antimicrobial peptides that directly target
pathogens, and also exert chemoattractant and immunomodulatory functions (De Yang et al.
2000). Results from our study show that environmental obesogens modulate production of
cathelicidin during adipocyte differentiation. Similarly, on termination day, 2-NAP upregulates
cathelicidin in a dose-dependent manner, whereas lead elevates cathelicidin at lower
concentrations but suppresses cathelicidin at high concentrations. The combination of 2-NAP and
lead at high concentrations results in no net effect.
Being obese or overweight usually is associated with a low-grade, chronic tissue
inflammation status, resulting not only in insulin resistance and type 2 diabetes, but also in other
obesity-induced disorders, such as cardiovascular disease and cancer (Lackey and Olefsky 2015).
Inflammation in adipose tissue results from infiltration and expansion of macrophages producing
inflammatory cytokines that interfere with insulin signaling and a loss of protective cells involved
in adipose homeostasis (Kohlgruber and Lynch 2015). These local macrophages are responsible
for most of the locally secreted TNF-α and for producing a considerable fraction of IL-6 and
inducible nitric oxide synthase. In addition, inflammation in adipose tissue is promoted by the
enhanced production of pro-inflammatory adipokines secreted by mature adipocytes (Kwon and
Pessin 2013). Therefore, adipocytes play an important role in linking obesity and inflammation as
well as immune responses. Here, in our study, we have shown the ability of two environmental
pollutants, 2-NAP and lead, to induce adipocyte differentiation and regulate production of the
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antimicrobial peptide cathelicidin which, as mentioned above, is known to mediate a wide range
of protective immune functions. However, altered cathelicidin expression is also associated with
chronic inflammation and chronic inflammatory autoimmune diseases (Choi and Mookherjee
2012). Thus, our findings provide new insight into how environmental pollutants could not only
be involved in the development of obesity by participating to increased adipogenesis and related
inflammatory responses, but also influence host defense at specific sites of adipocyte presence,
as for example beneath the skin where adipocytes form subcutaneous fat. However, it should be
noted that, at the present time, it is not clear whether or not 2-NAP and lead are able to
accumulate at specific sites.
Interestingly, our studies show not only that different pollutants exert different effects,
but also that these effects are dose-dependent in a non-linear fashion. Consequently, different
doses of different pollutants in different combinations may result in different modulatory effects
on adipogenesis and related inflammatory responses mediated by cathelicidin. As discussed
above, our results show that both 2-NAP and lead modulate cathelicidin expression. In addition,
when compared to the study by Zhang et al. (2015), our results indicate that 2-NAP and low doses
of lead induce cathelicidin production for an extended period of time. Indeed, Zhang et al.
demonstrate that production of cathelicidin in differentiating adipocytes is time-restricted. In
their study, cathelicidin expression was first detected in differentiating adipocytes on day 1,
peaked at day 2 to day 4, declined from day 4, and diminished after day 7 to 10 post-induction.
Results from our study show upregulated cathelicidin expression on day 8 in cells treated with 2NAP and lower doses of lead. Therefore, these two environmental pollutants may extend the
time frame expression profile of cathelicidin, possibly resulting in a prolonged inflammatory
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response. Thus, our results delineate the general steps of a potential pathway that leads from
exposure to 2-NAP and lead to the development of obesity. However, in vivo studies in animal
models are necessary to further explore this potential pathway.
Many different animal models have been developed or are being developed to study
obesity (Lutz and Woods 2012). Therefore, one of the challenges will be to choose the most
appropriate one, as such a model should be relevant not only to the development of
inflammation and obesity, but also to the route of exposure of environmental pollutants, which
might be differently metabolized in individual animal species and strains and may induce
different inflammatory pathways. Most traditional small rodent obesity models have been
developed on the general premise that a primary causal factor of obesity involves the interaction
of the brain with peripheral tissues such as gut, liver, pancreas and adipose tissue. However, the
concepts at the basis of the obesity-inflammation interrelationship are relatively recent, resulting
in less characterized corresponding models. Despite the current uncertainties related to these
models, it will be certainly worthwhile to carry out initial studies using the diet-induced obese
(DIO) C57BL/6J male mice model, which represent a pre-diabetic type 2 diabetes and obesity
model with elevated blood glucose and impaired glucose tolerance (Wang and Liao 2012), along
with the corresponding normal/lean mice.
Another critical implication of this study is to highlight the importance of studying the
combination of chemicals/pollutants based on the same exposure route. Combined exposure
research, which involves studies from different disciplines such as epidemiology, biology,
toxicology, and exposure science, has been conducted and emphasized by the National Institute
of Environmental Health Sciences (NIEHS) for more than three decades. Traditional toxicology
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focuses on the adverse effects and risk assessments of single chemicals. With the help of
epidemiological and biological studies, the relationships and mechanisms of single chemicals in
inducing diseases have also been revealed. However, actual exposure consists of a mixture of
chemical combinations, especially at low-dose levels, on a daily basis and for the entire human
lifespan. Therefore, it’s imperative to understand complex exposures and their co-effects on
human health and disease development, in order to minimize their impact. Here in our study, we
have used a well-characterized in vitro model to assess two chemicals for their individual and
combined effects on adipogenesis, and highlighted their combined effects.
Our results, by demonstrating at least some of the potential adverse health effects of 2NAP and lead, may also provide direct evidence that the United States Environmental Protection
Agency (US EPA) aims to collect in order to plan further studies that may lead to policy changes
aimed to reduce, for example, car emissions and air pollution. Additional studies should be
carried out to screen more individual chemicals, more combinations of chemicals from the same
or different exposure routes, and combinations of nonchemical stressors and chemical
exposures, as well as their effects on different diseases using other biological research models.
In conclusion, our results demonstrate that both 2-NAP and lead up-regulate adipocyte
differentiation and modulate antimicrobial peptide production, thus suggesting a potential role
for these two environmental pollutants in inducing inflammation and obesity. However,
treatment with these two chemicals in combination leads to different results, which are dosedependent. Thus, the evaluation of exposure to chemicals must take into account exposure to
mixtures, and needs to overcome the challenges posed by the many chemicals and the different,
variable combinations in which they are present in different environments at different times.
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